News and views
April 2026 Br J Cardiol 2026;33(2) doi:10.5837/bjc.2026.019
Correspondence – Population health management: giving GPs hypertension cases, not case-finding
Dear Sirs, Hypertension case-finding is a priority for the National Health Service (NHS) in England.1 Opportunistic testing of patients at community pharmacies, dentists...March 2026 Br J Cardiol 2026;33(1) doi:10.5837/bjc.2026.014
Correspondence – Platypnoea-orthodeoxia syndrome: anatomical relationship between atrial septum and aortic root
Dear Sirs, We thank Walker and colleagues for their interesting report of a 75-year-old man with platypnoea-orthodeoxia syndrome (POS) related to a large...March 2026 Br J Cardiol 2026;33:7
Obituary: Professor Adrian Brady
It is with great sadness that we mark the recent death of our friend and editorial board member, Professor Adrian Brady, aged...February 2026 Br J Cardiol 2026;33(1) doi:10.5837/bjc.2026.009
Correspondence – Delays to invasive coronary angiography in NSTE-ACS: insights from a tertiary PCI centre and the case for outpatient virtual wards
Dear Sirs, We read with interest the article by Kam et al. describing delays to invasive coronary angiography for patients with non-ST-elevation myocardial...February 2026 Br J Cardiol 2026;33(1)
Cardiorenal Forum ASM: working together to meet future needs in cardiorenal medicine
The 20th Annual Scientific Meeting (ASM) of the Cardiorenal Forum united clinicians and researchers to share advances in cardiovascular renal and metabolic care....November 2025 Br J Cardiol 2025;32:129
Sarah Birkhoelzer joins the BJC editorial board
We are delighted to announce that Dr Sarah Birkhoelzer is joining the British Journal of Cardiology editorial board representing Women in...October 2025 Br J Cardiol 2025;32:138
HEART UK – how important are lipids?
The 38th Annual Medical and Scientific Conference hosted by HEART UK delivered a comprehensive programme on cardiovascular prevention across the life course. Held...September 2025 Br J Cardiol 2025;32:112
Redefining risk: inclusion, innovation, and the future of cardiovascular care
This year’s British Cardiovascular Society (BCS) Annual Conference – held in Manchester 2nd–4th June 2025 – focused on the risks in cardiology that...September 2025 Br J Cardiol 2025;32:113 doi:10.5837/bjc.2025.042
Correspondence – Trigger-induced peri-operative atrial fibrillation in non-cardiac surgery: to anticoagulate, or not to anticoagulate, that is the question
Dear Sirs, We read with interest the narrative review by Wahab and colleagues.1 Target populations to whom systematic or opportunistic atrial fibrillation (AF)...July 2025 Br J Cardiol 2025;32:104
Book review – The beating heart: the art and science of our most vital organ
Author: Robin Choudhury Publisher: Bloomsbury Publishing (Apollo imprint), London 2024 ISBN: 9781837931743 Price: £35 (hardback), £24.50...June 2025 Br J Cardiol 2025;32:48
Obituary: Professor Douglas Chamberlain (1939-2025)
It is with great sadness that we mark the recent passing of Professor Douglas Chamberlain- one of the ‘greats’ of cardiology. Much of his...April 2025 Br J Cardiol 2025;32:48
BSH 2024: societies together – fostering synergy
The recent British Society for Heart Failure (BSH) 27th hybrid annual meeting highlighted the importance of building partnerships with collaborating societies and how...March 2025 Br J Cardiol 2025;32:6
In brief
We are pleased to announce that the BJC is in partnership with Cardiac Risk in the Young (CRY), we have a new forthcoming series...February 2025 Br J Cardiol 2025;32(1) doi:10.5837/bjc.2025.010
Correspondence: New-onset hypertension in COVID-19 patients
Dear Sirs, We read with interest the cross-sectional study by Kazemi et al. exploring the cardiovascular phenotypes of 690 hospitalised COVID-19 patients in...January 2025 Br J Cardiol 2025;32(1)
Heartfelt innovations: advances in cardiorenal care
We report from the 19th Annual Scientific Meeting of the Cardiorenal Forum held in London on 4th October 2024, which served as a...January 2025 Br J Cardiol 2025;32:6
Introducing Dr Paul Foley as a new Editor of the BJC
We are pleased to announce the appointment of Dr Paul Foley (Consultant Cardiologist, Great Western Hospitals, Swindon), as an Editor of The British Journal...December 2024 Br J Cardiol 2024;31(4)
HEART UK’s 37th AMSC 2024 – Hot topics in atherosclerosis and cardiovascular disease
HEART UK held its 37th Annual Medical and Scientific Conference between 10th–12th July. This year, the cholesterol charity took on an international theme, looking...September 2024 Br J Cardiol 2024;31(3)
British Cardiovascular Society annual conference, 2024: back to the patient
The British Cardiovascular Society (BCS) annual conference returned to the Manchester Central Convention Complex on the 3–5 June 2024. This year’s focus was...September 2024 Br J Cardiol 2024;31(3) doi:10.5837/bjc.2024.040
Correspondence: Prevention of stroke
Dear Sirs, In the recent article ‘Drug therapies for stroke prevention’, under the heading entitled ‘Control of blood pressure’, the authors specified that...August 2024 Br J Cardiol 2024;31(3) doi:10.5837/bjc.2024.036
Correspondence: Important safety aspects in SGLT2 inhibitor prescribing in heart failure
Dear Sirs, Sodium-glucose cotransporter type 2 (SGLT2) inhibitors (dapagliflozin, empagliflozin, canagliflozin) are increasingly being prescribed in the primary-care setting for cardiovascular indications. SGLT2...May 2024 Br J Cardiol 2024;31:73–5 doi:10.5837/bjc.2024.021
Correspondence: Other strategies for validating the diagnosis of heart failure
Dear Sirs, Given the fact that we are now practising medicine in an era where the standard of care is the optimisation of...March 2024
Celebrating over 30 years of the BJC
This year marks over 30 years of publishing the British Journal of Cardiology (BJC). Our first issue was in November 1993, as a new...March 2024 Br J Cardiol 2024;31:11
The failing heart and kidney: improving prevention and treatment
The Cardiorenal Forum’s recent 18th Annual Scientific meeting looked at the latest updates in the failing heart and kidney. Held in London on...February 2024 Br J Cardiol 2024;31:9–10
BSH 2023: collaboration, coordination and cooperation – 25in25
Multidisciplinary experts in heart failure care from across the UK and wider afield gathered for the recent 26th British Society of Heart Failure...November 2023 Br J Cardiol 2023;30:125 doi:10.5837/bjc.2023.038
Correspondence: ECG changes in right- and left-sided pneumothoraces
Dear Sirs, We read with interest the article by Yamamoto et al.,1 regarding the distinct electrocardiographic (ECG) manifestations in a large primary spontaneous...November 2023 Br J Cardiol 2023;30:125 doi:10.5837/bjc.2023.039
Correspondence: The co-existence of type A aortic dissection and pulmonary embolism
Dear Sirs, In response to the article by Acharya and Mariscalco on the diagnosis and acute management of type A aortic dissection,1 I...
October 2023 Br J Cardiol 2023;30(4)
HEART UK – lipids the best yet
HEART UK held its 36th Annual Medical and Scientific Conference over several days in July 2023 when the cholesterol charity reflected on the...
August 2023 Br J Cardiol 2023;30:86–9
BCS 2023: future-proofing cardiology for the next 10 years
The British Cardiovascular Society (BCS) annual conference returned to the Manchester Central Convention Complex on the 5th–7th June 2023. The focus this year was...July 2023 Br J Cardiol 2023;30:90
Obituary: Professor Gordon T McInnes
Cardiovascular medicine mourns the loss of one of its most well-known and loved figures, Gordon McInnes, who died suddenly on 30th May 2023, aged...July 2023 Br J Cardiol 2023;30:90
Obituary: Dr Mark Monaghan
With sadness we report the passing of editorial board member Professor Mark Monaghan, who led clinical and academic echocardiography for more than 30 years...June 2023 Br J Cardiol 2023;30:77–8 doi:10.5837/bjc.2023.019
Silent infective endocarditis with mucocutaneous stigmata, and delay in initiating echocardiography
Infective endocarditis (IE) without murmurs (silent IE) is an entity fraught with the risk of missed diagnosis. This hazard is attributable to a...June 2023 Br J Cardiol 2023;30:50
New BJC editorial board members
We are delighted to welcome three new members to the BJC editorial board. We will be collaborating with them on a new series of...April 2023 Br J Cardiol 2023;30:45–50
Fighting failure: reducing heart failure mortality by 25% over the next 25 years
To mark the 25th anniversary of the British Society of Heart Failure (BSH), the focus of its recent annual meeting was an aim...February 2023 Br J Cardiol 2023;30:12–15
Cardiorenal medicine – new targets, treatments and technologies
After two years of virtual meetings, the Cardiorenal Forum’s recent 17th Annual Scientific Meeting (ASM) was able to return to a face-to-face event...November 2022 Br J Cardiol 2022;29:131
Cardiologist elected RCP president
We send our congratulations to editorial board member, Dr Sarah Clarke, who has been elected the 122nd President of the Royal College of Physicians...November 2022 Br J Cardiol 2022;29:131
New BJC editorial board members
We are delighted to welcome four new members to our editorial...November 2022 Br J Cardiol 2022;29:134–6
Highlights from the BCS Annual Conference 2022: 100 years in cardiology
The British Cardiovascular Society (BCS) Annual Conference 2022 was held on the 6–8th June in Manchester, UK. This year saw a return to...October 2022 Br J Cardiol 2022;29:132–4
Hot topics in atherosclerosis and cardiovascular disease
HEART UK’s recent 35th Annual Medical Scientific Meeting blended a face-to-face meeting with virtual attendance to showcase the latest developments within the lipid community....August 2022 Br J Cardiol 2022;29(3)
The heart failure multidisciplinary team: reconnecting in the real world
One of the most difficult challenges presented to healthcare professionals during the COVID-19 pandemic has been maintaining standards of care in non-COVID related...July 2022
BJC accepted onto PubMed Central®
We are delighted to announce that the British Journal of Cardiology (BJC) has been accepted onto the prestigious international digital archive PubMed Central® after...May 2022 Br J Cardiol 2022;29:59
Book review
Age proof Author: Rose Anne Kenny Publisher: Lagom, London 2022 ISBN: 978 1 7887 0504 2 Price:...May 2022 Br J Cardiol 2022;29(2)
BSH position statement on heart failure with preserved ejection fraction
Heart failure with preserved ejection fraction (HFpEF) is an increasingly recognised form of heart failure that has been described as an emerging epidemic. It...March 2022 Br J Cardiol 2022;29:40 doi:10.5837/bjc.2022.010
Correspondence – Obstructive sleep apnoea and atrial fibrillation: a key omission in guidelines
Obstructive sleep apnoea and atrial fibrillation: a key omission in guidelines Dear Sirs, The National Institute for Health and Care Excellence (NICE) guidelines...February 2022
Dr Derek G Gibson
A personal tribute I was deeply saddened by the news that Dr Derek Gibson had passed away. I have lost a teacher, a friend,...January 2022 Br J Cardiol 2022;29:40 doi:10.5837/bjc.2022.006
Correspondence: Improving DVLA advice upon discharge after cardiac device implantation
Dear Sirs, Implantation of cardiac devices is increasing at a tremendous rate. Rate of implantation of permanent pacemakers (PPM) alone is rising at...January 2022 Br J Cardiol 2022;29:8
Freedom from failure: The British Society for Heart Failure Annual Meeting highlights
This year’s 24th British Society for Heart Failure annual meeting successfully brought together experts in heart failure from all over the UK as well...November 2021
HEART UK – Hypercholesterolaemia: familial or not?
Reflecting the times, HEART UK held its 34th Annual Medical and Scientific Conference virtually this year with sessions taking place over a number of...September 2021 Br J Cardiol 2021;28(3)
Book review
Heart valve disease: a guide for patients Author: John Chambers Publisher: NSHI, 2021 ISBN: 978-1-907882-30-2 Price: £8.99 Order via the BHVS website:August 2021
BJC and HaemSTAR announce new partnership
We are delighted to announce a media partnership between the British Journal of Cardiology (BJC) and HaemSTAR, which is a UK-wide network of passionate...July 2021 Br J Cardiol 2021;28:118 doi:10.5837/bjc.2021.035
Correspondence: Female medical students’ perspective on barriers to pursuing a career in cardiology
Female medical students’ perspective on barriers to pursuing a career in...July 2021 Br J Cardiol 2021;28:101 doi:10.5837/bjc.2021.036
Correspondence: Evaluating the use of a mobile device for detection of atrial fibrillation in primary care
Evaluating the use of a mobile device for detection of atrial fibrillation in primary...June 2021
Freedom from failure campaign aims to raise awareness of heart failure
The British Journal of Cardiology is pleased to support the British Society of Heart Failure’s (BSH’s) important new campaign ‘Freedom from failure’. Its aim,...June 2021
Book review – Cutting it: real-life tales of general and vascular surgery
Author: Kevin Lafferty Publisher: Powerhouse Publications, 2021 ISBN: 978-1838349004 Price...April 2021 Br J Cardiol 2021;28:53
Dr John Pittard
We report, with great sadness that our friend, Dr John Pittard, has died peacefully at home after a long illness, borne with incredible...March 2021
BJC and SCTS announce partnership
We are delighted to announce a partnership between the British Journal of Cardiology (BJC) and the Society of Cardiothoracic Surgery of Great Britain and...March 2021
Adrian Brady joins BJC editorial board
We are delighted to welcome Professor Adrian Brady to our editorial...February 2021
BJC and BSH announce partnership
We are delighted to announce a partnership between the British Journal of Cardiology (BJC) and the British Society for Heart Failure...February 2021
News from the BSH 23rd Annual Autumn Meeting: 2020 vision for heart failure
New perspectives in heart failure management and the development of the multidisciplinary workforce was the focus of the 23rd Annual Autumn Meeting of...January 2021 Br J Cardiol 2021;28:40 doi:10.5937/bjc.2021.006
Correspondence
Variations in surgical technique for permanent pacemaker implantation in West Midlands Dear Sirs, Around 34,000 permanent pacemakers are implanted in England annually.1 With an...December 2020
Women fare worse than men after severe heart attacks
Women face a 20% increased risk of developing heart failure or dying within five years after their first severe heart attack compared with men,...December 2020
Dapagliflozin approved in the EU for heart failure
AstraZeneca’s sodium-glucose co-transporter-2 (SGLT2 inhibitor) dapagliflozin has been approved in the European Union (EU) for the treatment of symptomatic chronic heart failure with reduced...December 2020
Urgent call for more heart failure nurses
The number of specialist heart failure nurses should be increased from one to four for every 100,000 people to meet the growing demand from...December 2020
Professors Peter Sleight and Tony Gershlick
We report with great sadness, the deaths of two very distinguished cardiologists: Professors Peter Sleight (Oxford University) and Anthony (Tony) Gershlick (University of Leicester)....December 2020
Sacubitril-valsartan benefits in cancer therapy-related cardiac dysfunction
A study from Argentina has assessed the effectiveness of sacubitril-valsartan in patients with cancer therapy-related cardiac dysfunction (CTRCD) treated in cardio-oncology units (December 2020
Inclisiran data shows good results LDL-C reduction across race and gender
Results from phase 3 studies with Inclisiran, a potential first-in-class small interfering RNA (siRNA) agent, have shown that it is well-tolerated and provides effective...December 2020
What should nanny do next? The government and obesity
Obesity in the UK is on the up. Prevalence of obesity is higher in more deprived communities, and it is linked to a range...September 2020 Br J Cardiol 2020;27:79 doi:10.5837/bjc.2020.029
Joint BACPR/BDA/PHNSG statement on nutrition and cardiovascular health post-COVID-19 pandemic
The British Association for Cardiovascular Prevention and Rehabilitation (BACPR), the British Dietetic Association (BDA) and the Public Health Nutrition Specialist Group (PHNSG) have issued...August 2020
Obituary: Dr Michael Schachter
We were shocked to hear the sad news of a dear friend passing away, Dr Michael Schachter (Senior Lecturer in Clinical Pharmacology, National Heart...June 2020
COVID-19 bulletin 3: clinical practice in the pandemic
Welcome to the third of our COVID-19 bulletins, which we hope will help you filter the continual stream of information published in both the...June 2020
COVID-19 and diabetes
Expert group practical recommendations: management of diabetes in COVID-19 patients Data show that most people with COVID-19 have co-morbidities, the most prevalent of which are...June 2020
COVID-19 and cardiac rhythm management
BHRS video series ‘Living with COVID-challenges and benefits of changes’ is the title of a series of online videos from the British Heart Rhythm Society...June 2020 Br J Cardiol 2020;27:50 doi:10.5837/bjc.2020.019
COVID-19 and cardiac rehabilitation
Joint BACPR/BCS/BHF statement on cardiac rehabilitation services The British Association for Cardiovascular Prevention and Rehabilitation (BACPR), the British Cardiovascular Society (BCS) and the British Heart...June 2020
COVID-19 and smartphone apps
Which apps have been increasingly useful to clinicians during the COVID-19 pandemic? The onset of the coronavirus pandemic has introduced many changes to the way...May 2020
COVID-19 bulletin 2: clinical practice in the pandemic
Welcome to the second of our COVID-19 bulletins, which we hope will help you filter the continual stream of information published in both the...May 2020 Br J Cardiol 2020;27:47–8 doi:10.5837/bjc.2020.015
COVID-19 and immunology
COVID-19 and vaccine development Trials in...May 2020
COVID-19 and primary care
Consultations during COVID-19: a review of current telemedicine...May 2020
COVID-19 and cardiorenal medicine
High rates of AKI in COVID-19 patients in ICU Recent reports have highlighted high rates of renal complications in patients with COVID-19 infection, notably...May 2020
COVID-19 and diabetes
Diabetes UK position statement Diabetes UK has published a position statement1 from the UK National Diabetes Inpatient COVID Response Group, which was formed at...May 2020
COVID-19 and mental health
Several useful resources are now available to support mental health among doctors and other health care professionals. With the significant impact of COVID-19 increasing...May 2020
COVID-19 and heart valve disease
The British Heart Valve Society (BHVS) has produced a statement on COVID-19 and heart valve disease to help answer patient queries. This is...April 2020
COVID-19 Bulletin 1: clinical practice in the pandemic
The COVID-19 crisis has brought with it a continual stream of information both in the lay press and also in that specifically aimed at...April 2020
COVID-19 and care of the elderly
Difficult conversations with the seriously ill “We will have to talk about dying during COVID-19 but the challenge for us is how to do this...April 2020
COVID-19 and diabetes
What we know so far Diabetes (together with hypertension and ischaemic heart disease) is one of the conditions that is notably associated with poorer outcomes...April 2020
COVID-19 and heart failure
Retention of essential heart failure services Heart failure teams are in demand due to their transferable skills, but there are significant risks with the redeployment...April 2020
COVID-19 and primary care
Managing COVID-19 in General Practice A free on-line course from St George’s University of London, designed for front-line clinicians, healthcare workers and professionals who are...April 2020
COVID-19 and respiratory medicine
New American Thoracic Society Guidance An American Thoracic Society-led international task force has released a guidance document to help clinicians manage COVID-19 patients in the...April 2020
COVID-19 in cancer patients
Cancer-associated thrombosis COVID-19 may predispose to both venous and arterial thromboembolism due to excessive inflammation, hypoxia, immobilisation and diffuse intravascular coagulation. Many patients receiving antithrombotic...April 2020
COVID-19 and cardiovascular disease
ESC Guidance on diagnosis and management of heart disease during COVID-19 The novel coronavirus not only causes viral pneumonia but also has major implications for...April 2020
Round up of COVID-19 e-learning, apps and websites
COVID-19: almost everything you need to know ‘Life in the fast lane’ (litfl.com), an Australian/New Zealand medical website, provides materials written...March 2020 Br J Cardiol 2020;27:10
Obituaries
With sadness, we report the recent deaths of two major figures in the world of cardiology, Professors Lionel Opie and Desmond Julian. We...March 2020 Br J Cardiol 2020;27:15–7
BSH: Improving quality and reducing inequality in heart failure
The popular annual autumn meeting of the British Society for Heart Failure (BSH) boasted a line-up of internationally recognised authorities in heart failure....March 2020 Br J Cardiol 2020;27:23
Book review – Practical cardio-oncology
Editor: Susan F Dent Publisher: CRC Press, Taylor & Francis Group, Boca Raton, 2019 ISBN: 9781138296961 Price: £77 Cardio-oncology...March 2020 Br J Cardiol 2020;27:26
Correspondence – Comparison of right radial artery pathway with left radial and femoral pathway on left internal mammalian artery imaging
Dear Sirs, The BJC recently published a valuable article demonstrating that the right radial pathway can be used to display the left internal...March 2020 Br J Cardiol 2020;27:18
In brief
In our in briefs this issue we cover: Tafamidis – a new treatment for amyloidosis; the NICE recommendation of patiromer for hyperkalaemia; an increase...January 2020 Br J Cardiol 2020;27:11–4
Cardiorenal Forum 2019: integrating care in cardiorenal medicine
The highly anticipated 14th Annual Scientific Meeting of the Cardiorenal Forum was held at The King’s Fund, London, on 4th October 2019. The focus...November 2019 Br J Cardiol 2019;26:128–9
In briefs
...October 2019 Br J Cardiol 2019;26(4)
News from ESC 2019
The European Society of Cardiology (ESC) Congress is the world’s largest meeting of cardiovascular professionals. This year, more than 32,000 delegates from over...September 2019 Br J Cardiol 2019;26:88–9
Updates from the American Diabetes Association 2019
With recent developments in medications and their clinical implications, the worlds of both diabetes and cardiology were focussed on the American Diabetes Association...September 2019 Br J Cardiol 2019;26:90
News from the BSH 21st Annual Autumn Meeting
‘The heart failure multidisciplinary team’ was the theme for the 21st Annual Autumn Meeting of the British Society of Heart Failure (BSH), which...September 2019 Br J Cardiol 2019;26:91
In brief
We are delighted to welcome two new editorial board members to The British Journal of Cardiology: Drs C Michael Gibson and Amar...May 2019 Br J Cardiol 2019;26:50
Quick takes from ACC.19: The American College of Cardiology 68th Annual Scientific Sessions
The American College of Cardiology (ACC.19) Annual Scientific Sessions represents one of the most exalted venues for investigators to present the latest studies...May 2019 Br J Cardiol 2019;26:49
New infective endocarditis information card available
A new infective endocarditis information card is available to help healthcare professionals meet the latest guidance for this...May 2019 Br J Cardiol 2019;26:52
In briefs
This new high-sensitivity troponin 1 assay (Vitros®, Ortho, pictured below) can deliver first troponin results in 15 minutes and can also identify low-risk patients...February 2019 Br J Cardiol 2019;26:9
British Geriatrics Society Cardiovascular Section Statement
On behalf of the Committee of the British Geriatrics Society Cardiovascular Section (BGS CV Section), we are delighted to announce that the British Journal...February 2019 Br J Cardiol 2019;26:10
London begins NHS video consultations in cardiology
Lewisham and Greenwich NHS Trust is the first NHS Trust in the country to offer video consultations for cardiology patients so they get...February 2019 Br J Cardiol 2019;26:10
New anticoagulant drug class in development
Data were recently presented on a new drug class, precision oral anticoagulants (PROACs) at the recent International Stroke Conference 2019, organised by the...February 2019 Br J Cardiol 2019;26:10
Guidelines for the safe practice of total intravenous anaesthesia
The first nationally agreed guidelines on the safe practice of total intravenous anaesthesia (TIVA) have been produced by The Association of Anaesthetists and...February 2019 Br J Cardiol 2019;26:10
Cytokine removal in sepsis and endocarditis
A recent randomised, controlled pilot study has shown significant stabilisation of the cardiovascular system in patients suffering from septic shock when treated with...February 2019 Br J Cardiol 2019;26:12
In brief
...December 2018
Cardiorenal Forum 2018: Updates and progress in cardiorenal medicine
This year’s fascinating and thought-provoking 13th Annual Scientific Meeting of the Cardiorenal Forum brought together experts from the closely linked specialties of nephrology, cardiology...November 2018 Br J Cardiol 2018;25:131–132
New NICE guidance and first nurse audit in heart failure
The National Institute of Health and Care Excellence (NICE) has published a new guideline on the diagnosis and management of chronic heart failure in...November 2018 Br J Cardiol 2018;25:131–132
European patient survey shows cancer-associated thrombosis
Blood clots are the second most common cause of preventable mortality in cancer patients. Approximately 4% to 20% of cancer patients experience venous thrombosis,...November 2018 Br J Cardiol 2018;25:131–132
Preventing potentially fatal anaesthetic accidents
A new study, from the Global Capnography Project (GCAP) and published in the journal Anaesthesia (doi: 10.1111/anae.14426), has identified a need for...November 2018 Br J Cardiol 2018;25:131–132
Future advances in bifurcation stenting?
Less than 5% of interventional cardiologists attempt left main bifurcation percutaneous coronary intervention stenting procedures because it is so complicated, according to estimates from...November 2018 Br J Cardiol 2018;25:131–132
Peripheral arterial disease assessment training tool
Clinicians who use handheld devices to ‘listen’ to the blood flow in patients’ lower limbs now have an online teaching aid that will improve...November 2018 Br J Cardiol 2018;25:133
In brief
Topics covered in brief in this issue include: self-monitoring of type 2 diabetes cuts costs; rivaroxaban licensed in patients with CAD or PAD; new...October 2018 Br J Cardiol 2018;25:135–7
News from ESC 2018: Not all HDL cholesterol is cardioprotective
Very high levels of high-density lipoprotein (HDL), the lipid that has been considered ‘good’ cholesterol, may be associated with an increased risk of...October 2018 Br J Cardiol 2018;25:135–7
News from ESC 2018: COMMANDER HF – rivaroxaban in heart failure…
Rivaroxaban, the direct oral, factor Xa inhibitor, does not reduce the risk of a composite end point of survival, myocardial infarction (MI) and...October 2018 Br J Cardiol 2018;25:135–7
News from ESC 2018: …and in VTE in the MARINER trial
The use of the oral anticoagulant rivaroxaban in medically ill patients for 45 days following hospital discharge showed there was no significant difference...October 2018 Br J Cardiol 2018;25:135–7
News from ESC 2018: Is it safe for women with heart disease to become pregnant?
“Usually”, appears to be the answer according to 10-year results from the Registry Of Pregnancy And Cardiac disease (ROPAC) a worldwide, prospective registry...October 2018 Br J Cardiol 2018;25(4)
News from the 10th British Society for Heart Failure Day for revalidation and training
‘All you need to know about heart failure – in one day’ was the promise of the 10th British Society for Heart Failure...October 2018 Br J Cardiol 2018;25:135–7
European Society of Cardiology 2018 Congress in briefs
This year’s meeting of the European Society of Cardiology (ESC) was held in Munich, Germany, from 25th–29th August...August 2018 Br J Cardiol 2018;25:95
HEART UK – Hot topics in atherosclerosis and cardiovascular disease
This year’s 32nd HEART UK Annual Medical and Scientific Conference reflects the current challenges and innovations within the lipid community. Whilst bringing variety...August 2018 Br J Cardiol 2018;25:90–1
News from EuroPCR 2018
Consistently attracting over 11,000 delegates, EuroPCR remains one of the largest interventional meetings on the planet and this year’s packed programme did not...August 2018 Br J Cardiol 2018;25:92
News from the BCS 2018
‘High performing teams’ was the theme for this year’s British Cardiovascular Society (BCS) Annual Conference 2018, held in Manchester in June. It was...June 2018 Br J Cardiol 2018;25:52
General news
News from EHRA 2018 The annual congress of the European Heart Rhythm Association (EHRA), a branch of the European Society of Cardiology (ESC), was...June 2018 Br J Cardiol 2018;25:53
In brief
Osteoporosis drug may have CV benefits The osteoporosis drug alendronate was linked with a reduced risk of cardiovascular (CV) death, heart attack, and stroke...March 2018
News from the Cardiorenal Forum 12th Annual Scientific Meeting – Improving treatments in cardiorenal patients
The advancement and quality improvement of treatments for cardiorenal patients was the focus of many presentations at the recent 12th Annual Scientific Meeting of...March 2018
In brief
Calling all post-CCT cardiologists! Have your say in gender differences, life work balance and other important issues. Consultant cardiologist, Dr Shareen Jaijee (Imperial College Healthcare...January 2018
News from the British Society for Heart Failure 2017
The recent British Society for Heart Failure (BSH) 20th Annual Autumn Meeting took as its theme ‘Three decades of heart failure’. Commemorating the...December 2017
Hyperkalaemia: who gets it, how frequent is it, what do I do and does it matter?
We are pleased to bring you a podcast from this year’s Cardiorenal Forum Annual Scientific Meeting, held in London on 13th October 2017. A...November 2017 Br J Cardiol 2017;24:129
NICE publishes updated familial hypercholesterolaemia guidance
The National Institute of Health and Care Excellence (NICE) has updated its clinical guideline (CG71) on the identification and management of familial hypercholesterolaemia...November 2017 Br J Cardiol 2017;24:129
REDUCE shows non-inferiority of short versus long DAPT in acute coronary syndrome
Results from the REDUCE trial presented at the 29th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium in Denver, USA, provide new insights into the...November 2017 Br J Cardiol 2017;24:130
Primary Care Cardiovascular Society announces its relaunch
Kathryn E Griffith (Secretary of the PCCS and Cardiovascular Lead for the Vale of York CCG) writes about the newly formed Primary Care Cardiovascular...November 2017 Br J Cardiol 2017;24:130
New series on insights from the Bradford Healthy Hearts project
We are delighted to announce a new series for 2018 on the award-winning Bradford Healthy Hearts Project. This collaborative improvement programme, which involves primary care,...November 2017 Br J Cardiol 2017;24:136
Cholesterol – a problem solved?
The 31st HEART UK Annual Medical and Scientific Conference took place at the University of Warwick from 5th – 7th July 2017. This year’s...November 2017 Br J Cardiol 2017;24:135
New test hopes to boost med school recruitment
A new advisory careers test has been designed with the aim of transforming the recruitment of potential doctors. It is hoped the test will...November 2017 Br J Cardiol 2017;24:135
Cardiff Met launches stroke research hub
Around 7,400 individuals will have a stroke in Wales each year, with 66,000 currently living with the after effects of a stroke. It is...November 2017 Br J Cardiol 2017;24:135
Rivaroxaban label update for extended VTE prevention
The European Commission (EC) has approved an update to the label of rivaroxaban (Xarelto®, Bayer) to include a 10 mg once daily dose for...November 2017 Br J Cardiol 2017;24:135
ESC congress returns to London
The ESC decision is a huge vote of confidence in London as a leading centre for medical research. London overcame stiff competition from other...November 2017 Br J Cardiol 2017;24:155
Anticoagulation group rebrands and partners with BJC
We are delighted that the BJC is now an offcial partner with Anticoagulation...October 2017
News from the European Society of Cardiology congress 2017
This year’s meeting of the European Society of Cardiology (ESC) provided results from a wide range of clinical trials on anticoagulation, lipid lowering, diet...October 2017
ESC 2017: CANTOS – a focus on inflammation and atherosclerosis
A consistent criticism of the ESC congress in recent years has been that, outside of the chronic heart failure arena at least, the late...October 2017
ESC 2017: COMPASS steers on anticoagulation in stable cardiovascular disease
In the same hotline session as CANTOS, the results of COMPASS (Cardiovascular Outcomes for People using Anticoagulation Strategies) also caught the attention. In...October 2017
ESC 2017: RE-DUAL PCI shows benefits for dabigatran
RE-DUAL PCI (the Randomized Evaluation of Dual Antithrombotic Therapy With Dabigatran vs Triple Therapy With Warfarin in Patients With Nonvalvular Atrial Fibrillation Undergoing Percutaneous...October 2017
ESC 2017: REVEAL – modest beneficial effects with anacetrapib
Results from the REVEAL (Randomized Evaluation of the Effects of Anacetrapib through Lipid Modification) study show anacetrapib, an investigational cholesteryl ester transfer protein (CETP)...October 2017
ESC 2017: New potassium binding drugs reviewed
The development of new potassium binding agents has increased interest in the field of hyperkalaemia management. This was the topic of a Vifor-sponsored satellite...October 2017
ESC 2017: Evidence supports treatment of iron deficiency in heart failure
As one in every two heart failure patients has iron deficiency, an appropriate and timely question asked during the meeting was: “should iron be...October 2017
ESC 2017: DETO2X – oxygen therapy does not improve survival in myocardial infarction
Oxygen therapy does not improve survival in patients with heart attack symptoms, according to late-breaking research presented at a hotline session and published...October 2017
ESC 2017: PURE shows we should revisit dietary fat guidelines
Researchers are calling for a reconsideration of global dietary guidelines in light of new data presented at the Congress on fat intake and cardiovascular...August 2017 Br J Cardiol 2017;24:95–6
General news
National audit shows improved heart failure...August 2017 Br J Cardiol 2017;24:97
In brief
‘Biological bypass’ shows promise in coronary artery...August 2017 Br J Cardiol 2017;24:98–9
Correspondence
Pitfalls in the interpretation of cardiopulmonary exercise testing data Dear Sirs Cardiopulmonary exercise testing (CPET) is non-invasive, safe,1 and reproducible.2 CPETs provide objective...August 2017 Br J Cardiol 2017;24:(3)
BCS 2017: spotlight on heart failure
The theme running through the recent 2017 British Cardiovascular Society (BCS) Annual Conference was ‘Cardiology at the extremes’. Few conditions in medicine can...June 2017 Br J Cardiol 2017;24:61
In brief
Air pollution linked to heart...June 2017 Br J Cardiol 2017;24:54
New editorial board members
We are delighted to announce two new members to our editorial board: Professor Una Martin and Dr Juan Pablo...April 2017 Br J Cardiol 2017;24:49-54
News from ACC.17
This year’s ACC.17 was a very newsy meeting with good news for lipid lowering, and the first outcome study for the new PCSK9 inhibitors...April 2017 Br J Cardiol 2017;24:56-8
News from the 9th BSH day for revalidation and training
Held on 2nd March 2017, the 9th British Society for Heart Failure (BSH) Training and Revalidation Day drew heart failure experts to London...April 2017 Br J Cardiol 2017;24:59-60
News from the British Heart Valve Society
An imaginative programme addressing head-on challenging debates within the valve community was presented at the recent British Heart Valve Society Annual Meeting. Held...March 2017
Anticoagulation news
A roundup of the latest news in the area of...March 2017 Br J Cardiol 2017;24:15–16
In brief
Blood test predicts silent heart disease...March 2017 Br J Cardiol 2017;24:8
Book review: Echocardiography – a practical guide for reporting and interpretation
Editors: Helen Rimington and John B Chambers...March 2017 Br J Cardiol 2017;24:20
Book review: Clinical handbook of cardiac electrophysiology
Editors: Benedict Glover and Pedro Brugada...
February 2017 Br J Cardiol 2017;24:13
Innovations in cardiorenal medicine
Enhanced understanding of organ fibrosis and novel therapeutic targets were the focus of many presentations at last year’s 11th Annual Scientific Meeting of...January 2017 Br J Cardiol 2017;24:14
News from the BSH 19th Annual Autumn Meeting
A ‘paradigm shift’ in the treatment of heart failure created an atmosphere full of excitement at the 19th British Society for Heart Failure (BSH)...December 2016 Br J Cardiol 2016;24:41
News from the AHA Scientific Sessions 2016
There was good news about the safety of a COX2 inhibitor, reduced bleeding with an oral anticoagulant and atheroma regression with a PCSK9 inhibitor...
November 2016 Br J Cardiol 2016;23:136
Cholesterol: the evolving story – HEART UK 30th annual conference
‘Cholesterol – the evolving story’ was the theme of this year’s HEART UK conference, covering primary and secondary care, patients and industry. The event...November 2016 Br J Cardiol 2016;23:132
BJC young cardiologists panel
With help from Dr Jubin Joseph, President, British Junior Cardiologists Association (BJCA), we are very pleased to have invited a panel of junior cardiologists...November 2016 Br J Cardiol 2016;23:132
Correspondence: NAFLD-associated cardiovascular disease – a role for coenzyme Q10 supplementation?
Dear...October 2016
Watch our ESC podcasts
Watch our podcast from the recent European Society of Cardiology (ESC) Congress, which highlights some of the key studies presented there with an...October 2016 Br J Cardiol 2016;23:(4)
Anticoagulation highlights from the ESC
With so much going on in the field of anticoagulation, our round-up of news in this area from the European Society of Cardiology (ESC)...October 2016
Pulmonary hypertension news from ESC and ERS
We round up the latest news in pulmonary hypertension (PH) from recent congresses. Dr Logan Thirugnanasothy (Clinical Research Fellow, Newcastle Pulmonary Hypertension Service, Freeman...October 2016 Br J Cardiol 2016;23:133–5
News from the ESC Congress 2016
This year’s European Society of Cardiology (ESC) Congress took place in Rome, Italy, from 27th–31st August 2016 and attracted over 33,000 delegates from across...August 2016 Br J Cardiol 2016;23:92
Correspondence: Sacubitril/valsartan: where should it sit in the heart failure pathway?
Dear...August 2016 Br J Cardiol 2016;23:96–7
Pulmonary hypertension news
In this report we review two major American meetings: the 36th Annual Meeting and Scientific Sessions of the International Society for Heart and Lung...July 2016 Br J Cardiol 2016;23:93
Highlights from international meetings: ACC, EAS and ADA
News highlights from the American College of Cardiology, European Atherosclerosis Society and American Diabetes...
July 2016 Br J Cardiol 2016;23:100
Cardiovascular applications:
apps – a beginner’s guide
Junior doctor Jonathan Bennett reviews cardiovascular apps and makes recommendations to fellow juniors of those he found most... June 2016 Br J Cardiol 2016;23:51
New ESC heart failure guidelines
Updated European Society of Cardiology (ESC) Guidelines for the diagnosis and treatment of acute and chronic heart failure have been...June 2016 Br J Cardiol 2016;23:51
NICE go-ahead for sacubitril/valsartan
The National Institute for Health and Care Excellence (NICE) has issued Technical Appraisal Guidance for sacubitril/valsartan (Entresto™, Novartis Pharmaceuticals). The drug has been...June 2016 Br J Cardiol 2016;23:56
Correspondence: Nicorandil, antithrombotic drugs, and non-variceal upper gastrointestinal bleeding
Dear...April 2016 Br J Cardiol 2016;23:(1)
Update from the 8th BSH Day for Revalidation and Training
A wide array of investigations is available to the heart failure specialist. Their proper utilisation requires knowledge of their indications, and proficiency in interpretation....March 2016 Br J Cardiol 2016;23:9
NICE quality standard on acute heart failure
The National Institute for Health and Care Excellence (NICE) has published a new quality standard in acute heart failure (QS103) to cover the...March 2016 Br J Cardiol 2016;23:9
Confusing NICE guidance on PCSK9 inhibitors
The cholesterol charity, HEART UK, has questioned NICE’s decisions on the new PCSK9 inhibitors evolocumab (Repatha®, Amgen) and alirocumab (Pralulent®, Sanofi Regeneron), which...March 2016 Br J Cardiol 2016;23:10–11
In brief
News in brief from the world of...
March 2016 Br J Cardiol 2016;23:15
Book review: Hypertension, 2nd edition
Editors: Nadar S, Lip GY...March 2016 Br J Cardiol 2016;23:14
Correspondence: ‘You look dishevelled’ – MI in a cardiologist diagnosed by his secretary
Correspondence from the world of...March 2016 Br J Cardiol 2016;23:14
Correspondence: Aldosterone levels and oedema score in a small series of HF patients
Correspondence from the world of...March 2016 Br J Cardiol 2016;23:14
Correspondence: Surviving an out-of-hospital arrest after negative tests: a GP’s experience
Correspondence from the world of...
February 2016 Br J Cardiol 2016;23:(1)
Cardiorenal medicine: challenges for the decade ahead
The most recent innovations in cardiorenal medicine and the challenges this specialty faces in the near future were the focus of the 10th Annual...February 2016 Br J Cardiol 2016;23:(1)
News from the BSH 18th Annual Autumn Meeting
‘Pathways of care’ was the theme for the 18th British Society for Heart Failure (BSH) Annual Autumn Meeting, held in London from 26–27th November...December 2015 Br J Cardiol 2016;23:(1)
Pulmonary hypertension news from AHA and ERS
We report highlights of pulmonary hypertension presentations from the most recently held European Respiratory Society (ERS) congress, held in Amsterdam, the Netherlands, from 26th–30th...
December 2015 Br J Cardiol 2015;22:146
Heart Rhythm Congress 2015
The 10th Heart Rhythm Congress was held October 4th–7th 2015 at the International Conference Centre (ICC) in Birmingham. This year’s event hosted a...
December 2015 Br J Cardiol 2015;22:145
‘Lipids in the community’ – HEART UK 29th annual conference
‘Lipids in the community’ was the general theme of this year’s HEART UK conference, attended by 200–250 participants, covering primary and secondary care,...December 2015 Br J Cardiol 2015;22:143–4
In brief
News in brief from the world of...October 2015 Br J Cardiol 2015;22:(4)
Focus on pulmonary hypertension
Pulmonary hypertension moves into new era The launch of new pulmonary hypertension (PH) guidelines was covered in several sessions at the recent...October 2015 Br J Cardiol 2015;22:138–142
News from the European Society of Cardiology Congress 2015
A record-breaking meeting of the European Society of Cardiology (ESC) was held in London this year with over 37,000 delegates from all over the...August 2015 Br J Cardiol 2015;22:88
London welcomes the 2015 ESC Congress
The British Cardiovascular Society (BCS) is the host Society for the European Society of Cardiology (ESC) Congress in 2015, which is being held...August 2015 Br J Cardiol 2015;22:89–90
New European Society of Cardiology recommendations published
Uninterrupted VKAs in ablation and device implantation The European Society of Cardiology (ESC) has recommended uninterrupted anticoagulation with vitamin K antagonists (VKAs) during ablation...August 2015 Br J Cardiol 2015;22:89–90
NICE quality standard on AF
The National Institute of Health and Care Excellence (NICE) has published a new quality standard on the treatment and management of atrial fibrillation...August 2015 Br J Cardiol 2015;22:89–90
‘Ultrasound on demand’ − how will it work in the UK?
An ‘Ultrasound on demand’ scheme has recently been launched in the UK. Aimed at providing access to the best technology at an affordable...August 2015 Br J Cardiol 2015;22:92–3
In brief
News in brief from the world of...
August 2015 Br J Cardiol 2015;22:96–7
Digoxin and the heart
In this regular series ‘ECGs for the fainthearted’ Dr Heather Wetherell will be interpreting ECGs in a non-threatening and simple way. In this...August 2015 Br J Cardiol 2015;22:98–9
Correspondence: Influences on novel oral anticoagulant prescribing – findings of a NICE scholarship project
Correspondence from the world of...August 2015 Br J Cardiol 2015;22:98–9
Correspondence: NICE guidelines for acute heart failure – long on pills, short on pumps
Correspondence from the world of...July 2015 Br J Cardiol 2015;22:(3)
News from the 17th International Symposium of Atherosclerosis
The latest in lipids medicine was presented at the 17th International Symposium of Atherosclerosis (ISA), which took place in Amsterdam, The Netherlands, from 23rd–26th...July 2015 Br J Cardiol 2015;22:(3)
Correspondence: influences on novel oral anticoagulant prescribing – findings of a NICE scholarship project
Correspondence from the world of...
June 2015 Br J Cardiol 2015;22:65–6
Hypertension, LVH, echo…and stuff
In this regular series ‘ECGs for the fainthearted’ Dr Heather Wetherell will be interpreting ECGs in a non-threatening and simple way. In this...
June 2015 Br J Cardiol 2015;22:63–4
The interview
We continue our series in which Consultant Interventionist Dr Michael Norell takes a sideways look at life in the cath lab…and beyond. In...June 2015 Br J Cardiol 2015;22:68
Correspondence: coenzyme Q10 supplementation for the treatment and prevention of heart failure
Correspondence from the world of...May 2015 Br J Cardiol 2015;22:59–60
News from the European Atherosclerosis Society Congress
Glasgow was the host of the recent 83rd Annual Congress of the European Atherosclerosis Society (EAS), held from 22nd–25th March 2015 and attended by...
April 2015 Br J Cardiol 2015;22:(2)
News from ACC.15
As well as the high-tech interventional advances including radial access percutaneous coronary intervention (PCI), new antibodies against cholesterol, and coronary angiography for heart disease...April 2015 Br J Cardiol 2015;22:(2)
News from the UK Stroke Forum
The UK’s premier stroke conference − the ninth UK Stroke Forum conference − took place on the 2nd−4th of December 2014 at the Harrogate...March 2015 Br J Cardiol 2015;22:(1)
Where there’s life, there’s hope: debating the Saatchi Bill
Opinion from the world of...March 2015 Br J Cardiol 2015;22:20–1
A significant collapse?
In this regular series ‘ECGs for the fainthearted’ Dr Heather Wetherell will be interpreting ECGs in a non-threatening and simple way. In this...
March 2015 Br J Cardiol 2015;22:22–4
Vive la différence?
We continue our series in which Consultant Interventionist Dr Michael Norell takes a sideways look at life in the cath lab…and beyond....March 2015 Br J Cardiol 2015;22:17
News from the Cardiorenal Forum 9th Annual Scientific Meeting – embracing the future, not forgetting the past
This year’s 9th Annual Scientific Meeting of the Cardiorenal Forum looked at glucose, gender, rhythm and risks. Experts in the fields of cardiology, diabetes...March 2015 Br J Cardiol 2015;22:19
In brief
News in brief from the world of...February 2015 Br J Cardiol 2015;22:18
News from the British Society for Heart Failure 17th Annual Autumn Meeting
'Yesterday’s problems, today’s solutions' was the theme of the 2014 autumn meeting of the British Society for Heart Failure (BSH). A wide-ranging programme...February 2015 Br J Cardiol 2015;22:11
Correspondence: accurate classification of chest pain
Correspondence from the world of...February 2015 Br J Cardiol 2015;22:11
Correspondence: don’t see their heart broken
Correspondence from the world of...February 2015 Br J Cardiol 2015;22:11
Correspondence: mortality due to rheumatic heart disease
Correspondence from the world of...February 2015 Br J Cardiol 2015;22:25
Book review
The antibody molecule: from antitoxins to therapeutic...January 2015 Br J Cardiol 2015;22:12–13
News from the American Heart Association Scientific Sessions 2014
The latest mega trial − IMPROVE-IT − dominated discussion at the recent American Heart Association (AHA) Scientific Sessions, with ezetimibe becoming the first non-statin...January 2015 Br J Cardiol 2015;22:(1)
Lipid highlights from the American Heart Association
Non-statin lipid lowering was the focus of several studies reporting at the recent American Heart Association (AHA) Scientific Sessions in Chicago, USA. It was...December 2014 Br J Cardiol 2014;21:139–40
In brief
News in brief from the world of...
December 2014 Br J Cardiol 2014;21:144–5
The curious incident…
We continue our series in which Consultant Interventionist Dr Michael Norell takes a sideways look at life in the cath lab…and beyond. In this...November 2014
Anticoagulation highlights from ESC 2014
Much of the European Society of Cardiology (ESC) 2014 Congress programme was devoted to important clinical issues such as management of arrhythmia, and stroke...October 2014 Br J Cardiol 2014;21:135–7
News from the ESC Congress 2014
This year’s European Society of Cardiology (ESC) Congress promised the strongest scientific programme yet and it did not disappoint. With 4,598 posters and oral...October 2014
Lipid highlights from ESC 2014
News from lipid studies was a major topic at the European Society of Cardiology (ESC) 2014 Congress. The theme this year was ‘Innovation and...October 2014
ESC Congress 2014 highlight podcasts
Our latest podcasts feature the European Society of Cardiology (ESC) Congress held recently in Barcelona, Spain, and highlight our selection of trials, registry data...October 2014 Br J Cardiol 2014;21:138
News from PCR London Valves 2014
PCR London Valves 2014 was a dynamic meeting outlining multiple technological advances and novel concepts. Held in London from 28th September 2014 – 1st...October 2014 Br J Cardiol 2014;21:142–3
Working through an abnormal ECG
In this new regular series ‘ECGs for the fainthearted’ Dr Heather Wetherell will be interpreting ECGs in a non-threatening and simple way. She hopes...October 2014 Br J Cardiol 2014;21:146
Correspondence: from balloons to stents and back again?
Correspondence from the world of...October 2014 Br J Cardiol 2014;21:146
Correspondence: newer technologies and jugular venous pressure
Correspondence from the world of...October 2014 Br J Cardiol 2014;21:146
Correspondence: improving ECG competence and confidence: a local DGH perspective
Correspondence from the world of...October 2014 Br J Cardiol 2014;21:123
Switch to digital prize winners
Congratulations to the winners of our prize draw, Dr Naguib Hilmy (Whaddon Medical Centre, Bletchley) and Dr Yanish Purmah (City Hospital, Birmingham), who can...October 2014 Br J Cardiol 2014;21:146
BJC welcomes new editorial board members
We are proud to welcome the following new members to our editorial...September 2014 Br J Cardiol 2014;21:98
New NICE guidance published
Atrial...September 2014 Br J Cardiol 2014;21:98
The age of no retirement?
A national campaign has been launched to debate the opportunities in a society where we are living...September 2014 Br J Cardiol 2014;21:105
News from the British Cardiovascular Society 2014 Annual Conference
We report highlights from this year’s British Cardiovascular Society 2014 Annual Conference held on June 2nd–4th 2014. Sessions from the busy programme varied from...September 2014 Br J Cardiol 2014;21:104
Towards personalised medicine: HEART UK 28th Annual Conference
Towards personalised medicine was the general theme of this year’s HEART UK conference, attended by 230 clinical and nursing personnel and patients and held...
September 2014 Br J Cardiol 2014;21:106
Working from home
We continue our series in which Consultant Interventionist Dr Michael Norell takes a sideways look at life in the cath lab…and beyond. In this...September 2014 Br J Cardiol 2014;21:90
Correspondence: gender and outcome from acute myocardial infarction and secondary stroke
Correspondence from the world of...September 2014 Br J Cardiol 2014;21:119
Book review
Heart failure: a practical guide for diagnosis and...August 2014 Br J Cardiol 2014;21:(3)
Call to support cardiomyopathy survey
The Cardiomyopathy Association is calling for healthcare professionals to take part in a survey, as part of its drive to improve awareness and symptom...August 2014 Br J Cardiol 2014;21:103
News from the European Atherosclerosis Society Congress
Hola Madrid! More than 1,800 clinicians and scientists from 75 countries converged on Madrid, Spain, for the 52nd annual congress of the European Atherosclerosis...July 2014
Switch to digital prize winners
Congratulations to the winners of our prize draw, Ms Hannah Manos (Culm Valley Integrated Centre for Health) and Professor John Somauroo (Countess of Chester...July 2014 Br J Cardiol 2014;21:102
News from the 23rd European Stroke Conference
The European Stroke Conference meeting was held in Nice, France, from May 6th–9th 2014. It was a busy programme with over 1,500 abstracts presented,...June 2014 Br J Cardiol 2014;21:62–3
Can we trust our ECG machines?
The article on pages 47–8, by Drs Derek Rowlands and Philip Moore, highlights the importance of maintaining our clinical skills at electrocardiogram (ECG)...
June 2014 Br J Cardiol 2014;21:60–1
Managing outpatients: a personal approach
We continue our series in which Consultant Interventionist Dr Michael Norell takes a sideways look at life in the cath lab…and beyond. In...June 2014 Br J Cardiol 2014;21:51
Correspondence: aggressive risk factor modification: 30 year follow-up of IHD and non-haemorrhagic stroke
Correspondence from the world of...June 2014 Br J Cardiol 2014;21:51
Correspondence: assessing the clinical benefits of drugs for dyslipidaemia
Correspondence from the world of...June 2014 Br J Cardiol 2014;21:51
Correspondence: is it time for a re-assessment of EECP in the UK?
Correspondence from the world of...
April 2014 Br J Cardiol 2014;21:56–7
News from ACC.14
The 63rd Annual Scientific Session of the American College of Cardiology (ACC) − held in Washington DC, USA from March 29th−31st 2014 − held...
April 2014 Br J Cardiol 2014;21:52–3
JBS3 recommends lifetime CVD risk estimation
A new emphasis on estimating the lifetime risk of future cardiovascular disease (CVD) – rather than the current 10-year risk – has been recommended...
April 2014 Br J Cardiol 2014;21:(2)
A walk around the right heart
Dr Lindsey Tilling reports from the recent British Society of Heart Failure day for training and revalidation, held in...March 2014 Br J Cardiol 2014;21:9
NICE guidance updates on statins and secondary prevention
Draft guidance on statins The National Institute for Health and Care Excellence (NICE) is recommending that the threshold for starting statins for the preventive...March 2014 Br J Cardiol 2014;21:16
In brief
News in brief from the world of cardiology...March 2014 Br J Cardiol 2014;21:8
Correspondence: echocardiography and enlarged cardiothoracic ratio
Correspondence from the world of...
March 2014 Br J Cardiol 2014;21:20–1
It’s only words…
We continue our series in which Consultant Interventionist Dr Michael Norell takes a sideways look at life in the cath lab…and beyond. In this...March 2014 Br J Cardiol 2014;21:17–9
My top 10 tips for ECG interpretation
In this new regular series ‘ECGs for the fainthearted’ Dr Heather Wetherell will be interpreting ECGs in a non-threatening and simple way. Confident interpretation...March 2014 Br J Cardiol 2014;21:21, 28
Book reviews
Bennett’s cardiac arrhythmias: practical notes on interpretation and treatment, 8th...February 2014 Br J Cardiol 2014;21:10–11
News from the American Heart Association Scientific Sessions 2013
Highlights of the American Heart Association (AHA) Scientific Sessions 2013, held in Dallas, Texas, USA, last November included success with a fourth new oral...February 2014 Br J Cardiol 2014;21:15
News from the BSH 16th Annual Autumn Meeting
The 16th Annual Autumn Meeting of the British Society for Heart Failure (BSH) entitled ‘Making sense of acute heart failure’, was held on 28–29...February 2014 Br J Cardiol 2014;21:14
Building an effective business case to support heart failure services
The development of an effective business case for heart failure services was discussed at a meeting held at the Royal College of Physicians on...December 2013 Br J Cardiol 2014;21:12–3
Highlights from HRC 2013
The Heart Rhythm Congress (HRC) remains the largest and fastest growing heart rhythm meeting in the UK, providing education and training to promote diversity...December 2013 Br J Cardiol 2013;20:133-5
What’s hot in cardiorenal medicine
This year’s 8th Annual Scientific Meeting of the Cardiorenal Forum looked at clinical dilemmas in cardiorenal disease and co-morbidities. The meeting was held at...December 2013 Br J Cardiol 2013;20:160
Correspondence: national survey of patients with AF in the acute medical unit: a day in the life survey
Correspondence from the world of...
December 2013 Br J Cardiol 2013;20:138-9
Me doctor, you patient
We continue our series in which Consultant Interventionist Dr Michael Norell takes a sideways look at life in the cath lab…and beyond. In this...October 2013 Br J Cardiol 2013;20:130–2
News from the ESC Congress 2013
This year’s European Society of Cardiology (ESC) Congress took place in Amsterdam, The Netherlands, on 31st August – 4th September 2013. We report...
September 2013 Br J Cardiol 2013;20:99-100
The cycle of life
We continue our series in which Consultant Interventionist Dr Michael Norell takes a sideways look at life in the cath lab…and beyond. In this...August 2013 Br J Cardiol 2013;20:92-93
News from EHRA: encouraging news on anticoagulants
Dr James Rosengarten reports highlights from the European Heart Rhythm Association (EHRA) Europace 2013 meeting held recently in Athens,...August 2013 Br J Cardiol 2013;20:92-93
News from EHRA: PREFER AF
Dr James Rosengarten reports highlights from the European Heart Rhythm Association (EHRA) Europace 2013 meeting held recently in Athens,...August 2013 Br J Cardiol 2013;20:92-93
News from EHRA: depression screening in AF clinics recommended
Dr James Rosengarten reports highlights from the European Heart Rhythm Association (EHRA) Europace 2013 meeting held recently in Athens,...August 2013 Br J Cardiol 2013;20:92-93
News from EHRA: AF patient website launched
Dr James Rosengarten reports highlights from the European Heart Rhythm Association (EHRA) Europace 2013 meeting held recently in Athens,...August 2013 Br J Cardiol 2013;20:92-93
News from EHRA: biomarkers may help stratify sudden cardiac death risk
Dr James Rosengarten reports highlights from the European Heart Rhythm Association (EHRA) Europace 2013 meeting held recently in Athens,...August 2013 Br J Cardiol 2013;20:92-93
News from EHRA: new ‘user friendly’ guidelines on pacing and CRT
Dr James Rosengarten reports highlights from the European Heart Rhythm Association (EHRA) Europace 2013 meeting held recently in Athens,...August 2013 Br J Cardiol 2013;20:105
Book review
The heart of Leonardo Authors: Francis C Wells Publisher: Springer, London 2013 ISBN: 9781447145301 Price:...June 2013 Br J Cardiol 2013;20:52
New practical guide to new oral anticoagulants from ESC
A ‘practical guide’ to the new oral anticoagulants that have recently become available as an alternative to warfarin for patients with atrial fibrillation has...June 2013 Br J Cardiol 2013;20:52
ESC statement supports renal denervation
The European Society of Cardiology has issued a consensus statement, which says that catheter-based renal denervation can be considered a therapeutic option in patients...June 2013 Br J Cardiol 2013;20:52
TAVI use in Europe varies widely
Transcatheter aortic-valve implantation (TAVI) was performed in around 34,500 patients in 11 European countries in the first five years following European approval of the...June 2013 Br J Cardiol 2013;20:52
Lab grown human heart implants becoming reality
Tissue-engineered human organs – the next generation of treatments for chronic heart diseases – will soon become a multi-billion dollar medical market according to...June 2013 Br J Cardiol 2013;20:52
ECGs for the faint hearted
Can you tell right from left bundle branch block? Are they clinically...
June 2013 Br J Cardiol 2013;20:59-60
Take a letter, Miss Jones…
We continue our series in which Consultant Interventionist Dr Michael Norell takes a sideways look at life in the cath lab…and beyond. In this...April 2013 Br J Cardiol 2013;20:54-5.
News from the American College of Cardiology Scientific Session 2013
Highlights of the American College of Cardiology (ACC) meeting held in San Francisco last month included the first study to show a benefit of...April 2013 Br J Cardiol 2013;20:57-8.
SHARPening up research in Scotland
The Scottish Heart and Arterial disease Risk Prevention (SHARP) charity has aimed to reduce and prevent premature morbidity and mortality from cardiovascular disease in...April 2013 Br J Cardiol 2013;20:46
Correspondence: feasibility of using CTCA in patients with acute low-to-intermediate likelihood chest pain in a DGH
Correspondence from the world of...April 2013 Br J Cardiol 2013;20:(2)
BSH 5th annual heart failure day for training and revalidation
Treatment of chronic heart failure (HF) is underpinned by a firm evidence base. The same cannot be said for most acute HF but this...April 2013 Br J Cardiol 2013;20:80
Book reviews
Practical handbook of advanced interventional cardiology: tips and tricks (4th edition) Authors: Nguyen T, Hu D, Chen SL, et al. Publisher: Wiley-Blackwell, 2012 ISBN: 9780470670477 Price:...March 2013 Br J Cardiol 2013;20:13
BJC Learning angina programme
www.bjcardio.co.uk/learning Editors: Mulcahy D, Purcell H Publisher: Medinews Cardiology Limited, London, 2012 ISBN:...March 2013 Br J Cardiol 2013;20:16-17
In brief – cardiology news roundup
News in brief from the world of...
March 2013 Br J Cardiol 2012;20:25-6
Guess who’s coming into the cath lab?
We continue our series in which Consultant Interventionist Dr Michael Norell takes a sideways look at life in the cath lab…and beyond. In this...March 2013 Br J Cardiol 2013;20:37
Book reviews
Hypertension Editors: Bakris G, Baliga RR Publisher: Oxford University Press USA, USA, 2012 ISBN: 978-0-19-975490-8 Price:...February 2013 Br J Cardiol 2013;20:18-9
News from the BSH 15th Annual Autumn Meeting
The 15th Annual Autumn Meeting of the British Society for Heart Failure (BSH) entitled 'Heart failure, a multidisciplinary approach', was held on 29th–30th November...February 2013
British Society of Heart Failure Young Investigators’ Award
Three abstracts of outstanding quality were presented for the Young Investigators' Award at the British Society of Heart Failure's 15th Annual Autumn...December 2012 Br J Cardiol 2013;20:14–5
News from the American Heart Association Scientific Sessions 2012
Highlights of the American Heart Association 2012 meeting held on 3rd - 7th November 2012 in Los Angeles, USA, included a win for surgery...December 2012 Br J Cardiol 2013;20:20–1
News from the 7th Annual Scientific Meeting of the Cardiorenal Forum
This year's 7th Annual Scientific Meeting of the Cardiorenal Forum looked at diabetes and other co-morbidities in relation to cardiorenal disease. The meeting was...November 2012 Br J Cardiol 2012;19:152
News from the ESC Congress 2012
Highlights of the European Society of Cardiology (ESC) 2012 Congress held in Munich, Germany on August 25th–29th included the first ever randomised trial addressing...November 2012 Br J Cardiol 2012;19:155
Highlights from HRC 2012
This year's Heart Rhythm Congress (HRC 2012), held in Birmingham from 23rd-26th September, was the largest to date showing the growing interest in this...November 2012 Br J Cardiol 2012;19:158–9
New diabetes guidelines stress individual patient needs
The European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) have published new guidelines on the treatment of type...November 2012 Br J Cardiol 2012;19:158–9
KEEPS: reassurance on heart effects of HRT
Four years of hormone-replacement therapy (HRT) started soon after the onset of the menopause improved depression and anxiety in healthy women without promoting or...November 2012 Br J Cardiol 2012;19:158–9
More on diabetes risk with statins
Another study has found a slight increase in fasting glucose levels in patients at increased risk of type 2 diabetes taking statins. The study...November 2012 Br J Cardiol 2012;19:161
Lessons learnt from a tragic loss
Correspondence from the world of...
November 2012 Br J Cardiol 2012;19:162-4
Decision by consensus: more political correctness or a genuine improvement in care?
We continue our series in which Consultant Interventionist Dr Michael Norell takes a sideways look at life in the cath lab…and beyond. In this...August 2012 Br J Cardiol 2012;19:107–10
New ESC Guidelines on heart failure and CVD prevention
The European Society of Cardiology (ESC) has published two new guidelines – ESC Guidelines for the diagnosis and treatment of acute and chronic heart...August 2012 Br J Cardiol 2012;19:107–10
HDL particles may be key to risk
With all the recent controversy about whether raising high-density lipoprotein (HDL) is actually a worthwhile strategy in the battle against heart disease, a new...August 2012 Br J Cardiol 2012;19:107–10
Stricter food policies could dramatically cut heart disease deaths
Tougher government policies on diet could prevent 30,000 cardiovascular deaths a year in the UK, according to a new study. Moves suggested include banning...August 2012 Br J Cardiol 2012;19:107–10
Lancet highlights damage of physical inactivity
Physical inactivity is responsible for 6% of the worldwide burden of coronary heart disease and 7% of type 2 diabetes cases, as well as...August 2012 Br J Cardiol 2012;19:107–10
Impressive results for polypill in new UK study
A new study of the polypill has shown large reductions in blood pressure and cholesterol levels, which if maintained long-term could translate into a...August 2012 Br J Cardiol 2012;19:107–10
New data reassures on bleeding risk with dabigatran in surgery patients
New data from the RE-LY trial show that dabigatran is associated with similar rates of bleeding and thrombotic complications to warfarin in patients who...August 2012 Br J Cardiol 2012;19:107–10
NICE – final guidance on rivaroxaban in DVT
The National Institute for Health and Clinical Excellence (NICE) has issued its final appraisal determination (FAD) on the use of rivaroxaban, as an alternative...
August 2012 Br J Cardiol 2012;19:115–6
I guess that’s why they call it ‘The Blues’
We continue our series in which Consultant Interventionist Dr Michael Norell takes a sideways look at life in the cath lab…and beyond. In this...
August 2012 Br J Cardiol 2012;19:119-121
A career in academic cardiology
Introduction Cardiology represents a unique blend of hands-on practical application combined with sound physiological principles supported by a vast and continually evolving evidence base. Entry...August 2012 Br J Cardiol 2012;19:116
Optimised beta blocker therapy in heart failure A gap between training and provision: a primary-care based ECG survey
Correspondence from the world of...July 2012
Beta blockers underused in the elderly with lung disease
The underuse of beta blockers in elderly patients with lung disease was highlighted at the recent British Society for Heart Failure (BSH) 4th annual...May 2012
Position statement on anti-arrhythmic drugs
Evidence-based recommendations for the practical use of anti-arrhythmic drugs and dronedarone in particular are published today on BJC online. The recommendations have been made...May 2012 Br J Cardiol 2012;19:57
ESC issues position paper on new anticoagulants
In a new position paper, the European Society of Cardiology welcomes the new oral anticoagulants for use in atrial fibrillation (J Am Coll Cardiol...May 2012 Br J Cardiol 2012;19:57
ARB number 8 launched in UK
A new angiotensin receptor blocker (ARB), azilsartan medoxomil (Edarbi®, Takeda) has been launched in the UK for the treatment of hypertension. It is the...May 2012 Br J Cardiol 2012;19:58
Ivabradine receives heart failure licence
Ivabradine (Procoralan®, Servier) has been approved for use in heart failure. The licence has been granted for use in patients in New York Heart...
May 2012 Br J Cardiol 2012;19:59–61
News from the American College of Cardiology Scientific Session 2012
Highlights of the recent American College of Cardiology (ACC) meeting, 24th–27th March 2012, held in Chicago, USA, included a study showing the benefit of...
May 2012 Br J Cardiol 2012;19:62–3
“You want it by when?”
We continue our series in which Consultant Interventionist Dr Michael Norell takes a sideways look at life in the cath lab… and beyond. In...May 2012 Br J Cardiol 2012;19:56
Introductory cardiovascular magnetic resonance
Society for Cardiovascular Magnetic Resonance Cardiovascular magnetic resonance (CMR) is playing an increasing role in the diagnosis and classification of heart disease, with as many...March 2012 Br J Cardiol 2012;19:15
Correspondence: Chest pain
Correspondence from the world of...March 2012 Br J Cardiol 2012;19:9
Primary Care Cardiovascular Society announces closure
The British Journal of Cardiology is sorry to report the closure of the Primary Care Cardiovascular Society (PCCS), which ceased operating at on the...March 2012 Br J Cardiol 2012;19:10
MI deaths continue to fall sharply in England
The death rate from heart attacks in England halved in the eight years between 2002 and 2010, new data...March 2012 Br J Cardiol 2012;19:10
Aspirin in primary prevention: new meta-analysis
A new meta-analysis has shown that cardiovascular benefits of aspirin in the primary prevention population are balanced by the risk of...March 2012 Br J Cardiol 2012;19:10
TRA-2P: new antiplatelet drug reduces CV events but ups bleeding
Top-line results of the TRA-2P study have shown that Merck’s novel antiplatelet agent, vorapaxar, reduced the primary ischaemic end point of the study, but...March 2012 Br J Cardiol 2012;19:11
Statins associated with increased risk of diabetes
More concern about the risk of diabetes with statins has been voiced after new data from the Women’s Health Initiative (WHI) has shown a...March 2012 Br J Cardiol 2012;19:11
Telehealth rollout to accelerate
Prime Minister, David Cameron, has announced that telecare and telehealth systems will be rolled out to the homes of three million people over the...March 2012 Br J Cardiol 2012;19:11
MHRA issues advice on dabigatran
As adverse event reports of bleeding with the new oral anticoagulant, dabigatran, are being publicised, many regulatory authorities are issuing alerts reminding that caution...March 2012 Br J Cardiol 2012;19:16
Cardiovascular disease – everyday management
The highlight of this year’s SHARP Annual Scientific Meeting, held at Dunkeld House, Perthshire, on 24th–25th November 2011, was a mini symposium held in...March 2012 Br J Cardiol 2012;19:15
Correspondence: Safe practice in TOE
Correspondence from the world of...March 2012 Br J Cardiol 2012;19:15
Correspondence: Anaemia in CHF
Correspondence from the world of...March 2012 Br J Cardiol 2012;19:15
Correspondence: Iodine deficiency and cholesterol
Correspondence from the world of...March 2012 Br J Cardiol 2012;19:15
Correspondence: Specialty training
Correspondence from the world of...February 2012 Br J Cardiol 2012;19:16
Care for the individual patient
The 14th British Society for Heart Failure (BSH) annual meeting, entitled ‘Care for the individual patient’, was held in late November at the Queen...October 2011 Br J Cardiol 2011;18:203
Changes to hypertension guidelines
The National Institute for Health and Clinical Excellence (NICE) has updated its guideline on hypertension, making a number of new recommendations regarding both the...October 2011 Br J Cardiol 2011;18:203
Dronedarone to be restricted
The European Medicines Agency has recommended that the anti-arrhythmic, dronedarone (Multaq®), should be...October 2011 Br J Cardiol 2011;18:203
Rivaroxaban reduces events in ATLAS-ACS
...
October 2011 Br J Cardiol 2011;18:208–210
News from the ESC Congress 2011
Highlights of the European Society of Cardiology (ESC) 2011 Congress, held in Paris, France, from 27th–31st August, included encouraging results with the third new...
October 2011 Br J Cardiol 2011;18:212-213
Quality in CVD care – taking the lead in the new NHS
This year’s 14th Annual Scientific Meeting of the Primary Care Cardiovascular Society (PCCS), held in Bristol, 28th–30th September 2011, highlighted the controversial reforms in...
October 2011 Br J Cardiol 2011;18:214-215
Is it a bird? Is it a plane? No, it’s radial man!
We continue our series in which Consultant Interventionist Dr Michael Norell takes a sideways look at life in the cath lab…and beyond. In this...October 2011 Br J Cardiol 2011;18:217
Correspondence
Correspondence from the world of cardiology....August 2011 Br J Cardiol 2011;18:153-154
Latest news from the world of cardiology
NHS Improvement: what is the future for heart and stroke services? On the eve of his retirement, the outgoing National Director for Heart Disease and...August 2011 Br J Cardiol 2011;18:158–9
Old problems, new solutions: the HEART UK annual conference
HEART UK – The Cholesterol Charity held its 25th annual conference at Warwick University from 6th-8th July 2011, entitled ‘Partners in Prevention - Lipids...
August 2011 Br J Cardiol 2011;18:161–162
British Cardiovascular Society: Annual Conference 2011 and education plans for 2011-2012
In this sixth article from the British Cardiovascular Society (BCS), Dr Sarah Clarke, BCS Vice-President Education & Research, writes about this year’s Annual Conference...
August 2011 Br J Cardiol 2011;18:164–66
The Oblique View – Watch your language!
We continue our series in which Consultant Interventionist Dr Michael Norell takes a sideways look at life in the cath lab…and beyond. In this...August 2011 Br J Cardiol 2011;18:179
Correspondence
Correspondence from the world of...June 2011 Br J Cardiol 2011;18:105–8
News from the American College of Cardiology Scientific Session 2011
Highlights of the recent American College of Cardiology (ACC) meeting, held in New Orleans, USA, on 2nd – 5th April 2011, included the promise...June 2011 Br J Cardiol 2011;18:111–12
In brief
News from the world of...
June 2011 Br J Cardiol 2011;18:113–14
Heart failure: what’s new? The 2011 BSH medical training meeting
The latest evidence in heart failure was presented at the 3rd Annual British Society of Heart Failure (BSH) medical training meeting, which took place...
June 2011 Br J Cardiol 2011;18:115–116
Physician heal thyself? Not on your nelly
We continue our series in which Consultant Interventionist Dr Michael Norell takes a sideways look at life in the cath lab…and beyond. In this...June 2011
British Cardiovascular Society: plans for 2011
In this fifth article from the British Cardiovascular Society (BCS), Professor Keith Fox, BCS President, looks to the future of a changing healthcare...June 2011 Br J Cardiol 2011;18:118
Valve disease: the forgotten epidemic
A report from the first training day of the British Heart Valve Society, held recently at the Royal Society of Medicine,...June 2011
Correspondence
News from the world of...April 2011
TRIGGER-PCI stopped early
News from the world of...April 2011
Acute coronary syndrome costs billions per year
News from the world of...April 2011
More suggestion of harm with rosiglitazone
News from the world of...April 2011
Metformin best first-line drug for type 2 diabetes
News from the world of...April 2011
Increased potassium intake cuts stroke
News from the world of...April 2011
Mortality signal still showing at five years in ACCORD
News from the world of...April 2011
No benefit from lowering blood pressure in acute stroke
News from the world of...April 2011
Central obesity no worse than other types for cardiovascular risk
News from the world of...April 2011
Could use of generic ARBs save the NHS millions?
News from the world of...
April 2011
British Cardiovascular Society: clinical standards
In this fourth article from the British Cardiovascular Society (BCS), Dr Simon Ray, BCS Vice-President for Clinical Standards, summarises the major issues of the moment. The...April 2011
Telehealth programme shows reduced hospital admissions and high patient satisfaction
A survey it carried out following the introduction of telehealth monitoring to the homes of 74 people suffering from long-term conditions in NHS Birmingham...February 2011 Br J Cardiol 2011;18:9-10
ACCELERATE: start antihypertensive therapy with two drugs
Patients who start antihypertensive treatment with two drugs do better than those initially given just one, according to the ACCELERATE...February 2011 Br J Cardiol 2011;18:9-10
BJC supports Stroke Association 2011 initiatives
The UK Stroke Association is in the process of planning an awareness campaign around atrial fibrillation (AF) and its link to stroke. The campaign...February 2011 Br J Cardiol 2011;18:9-10
BJC prize for innovation in cardiac rehabilitation
Congratulations to Barbara Conway, Cardiovascular Clinical Team Leader at NHS Darlington, who has won the British Journal of Cardiology Prize for Innovation in Cardiac...February 2011 Br J Cardiol 2011;18:59-61
Ticagrelor approved in Europe
Ticagrelor (Brilique®, Astra Zeneca) has received authorisation from the European Medicines Agency for use in combination with aspirin in the prevention of atherothrombotic events...February 2011 Br J Cardiol 2011;18:9-10
Heart failure registry looks at mortality with ARBs
Use of the angiotensin receptor blocker (ARB) candesartan was associated with a lower mortality than losartan in a Swedish registry of heart failure...February 2011 Br J Cardiol 2011;18:9-10
Statins and CV events in patients with abnormal liver tests
According to a recent study, led by Vasilis Athyros from the Hippokration University Hospital in Thessaloniki, Greece, and Dimitri Mikhailidis from University College London,...
February 2011 Br J Cardiol 2011;18:11-3
News from the American Heart Association Scientific Sessions 2010
News from the world of cardiology....
February 2011 Br J Cardiol 2011;18:17-8
Beyond cardiovascular disease: SHARP Scientific Meeting 2010
The 2010 Scientific Meeting of the Scottish Heart and Arterial Prevention Group (SHARP) took place in November 2010 and addressed, in detail, the interface...
February 2011 Br J Cardiol 2011;18:19-20
British Cardiovascular Society: training division
Welcome to the third of the series of news and reviews from the British Cardiovascular Society (BCS). In this article, Dr Jim Hall, Vice-President for...
February 2011 Br J Cardiol 2011;18:21-2
South by Southwest
We continue our series in which Consultant Interventionist Dr Michael Norell takes a sideways look at life in the cath lab…and beyond. In this...November 2010 Br J Cardiol 2010;17:259-63
Rosiglitazone suspended in Europe
The diabetes drug, rosiglitazone (Avandia®, GlaxoSmithKline), has been suspended in Europe, following a review of cardiovascular safety data by the European Medicines Agency...
November 2010 Br J Cardiol 2010;17:259-63
Home monitoring of INR is a viable alternative
Home INR testing in patients taking warfarin was associated with similar event rates as monthly high-quality clinic testing in a new study, which the...
November 2010 Br J Cardiol 2010;17:259-63
Mediterranean diet reduces new-onset diabetes
Individuals at high cardiovascular risk but without diabetes who followed a Mediterranean diet had half the rate of new-onset diabetes over four years compared...November 2010 Br J Cardiol 2010;17:259-63
Sugary drinks linked to increased diabetes and metabolic syndrome
Consumption of just one or two sugar-sweetened drinks per day is associated with a 26% greater risk of developing type 2 diabetes and a...November 2010 Br J Cardiol 2010;17:259-63
Compressions-only CPR may be best?
Bystanders attending to an adult in cardiac arrest should perform the chest-compression-only technique of cardiopulmonary resuscitation (CPR), a new meta-analysis...November 2010 Br J Cardiol 2010;17:259-63
Cardiovascular risk increases after invasive dental treatment
The risk of cardiovascular events increases sharply in the month following invasive dental treatment, a new study...November 2010 Br J Cardiol 2010;17:259-63
PARTNER: transcatheter valves show striking benefits in aortic stenosis patients unsuitable for surgery
Transcatheter aortic valve replacement (TAVI) was associated with much better outcomes than standard care in patients with severe aortic disease unable to undergo surgery...November 2010 Br J Cardiol 2010;17:259-63
Xience V stent riding high in four new trials
Four separate trials, all presented at the Transcatheter Cardiovascular Therapeutics (TCT) meeting in Washington DC, USA, showed impressive results with the new Xience V™...
November 2010 Br J Cardiol 2010;17:259-63
National Cholesterol Week launched to raise awareness of hypercholesterolaemia
HEART UK held its first ever National Cholesterol Week recently and highlighted the importance of knowing your cholesterol at a Parliamentary Reception at the...November 2010 Br J Cardiol 2010;17:259-63
First approvals of dabigatran for stroke prevention in AF patients in the US and Canada
The wait for a more convenient replacement for warfarin for use in atrial fibrillation (AF) patients is finally over in North America, where dabigatran...November 2010 Br J Cardiol 2010;17:259-63
Exercise in older people improves heart function but not structure
Exercise can improve arterial function, aerobic capacity and induce left-ventricular remodelling in people over 65 but it does not reverse the cardiac stiffening effect...
November 2010 Br J Cardiol 2010;17:259-63
Statins recommended for everyone over 40 with diabetes
People with diabetes over 40 years of age should be taking a statin to reduce their risk of stroke or coronary events, according to...November 2010 Br J Cardiol 2010;17:259-63
Coenzyme Q10 may help in heart failure
A small study carried out by doctors in Texas, USA, on patients with heart failure suggests that giving a supplement of coenzyme Q10 can...
November 2010 Br J Cardiol 2010;17:269
British Cardiovascular Society: education in cardiology
The British Cardiovascular Society (BCS) has always had a significant role in education for cardiologists, largely through the BCS Annual Conference. The recognition of...September 2010 Br J Cardiol 2010;17:209
Latest NICE guidance on chronic heart failure
The National Institute for Health and Clinical Excellence (NICE) has published new guidance on the management of chronic heart failure. This updates and replaces...
September 2010 Br J Cardiol 2010;17:211-14
News from the 2010 Congress of the European Society of Cardiology
News from the world of cardiology....
September 2010 Br J Cardiol 2010;17:220-21
The British Cardiovascular Society: an overview
Welcome to the first of a regular series of news and reviews from the British Cardiovascular Society (BCS). Many of you will already be...September 2010 Br J Cardiol 2010;17:209
In Brief
News in brief from the world of cardiology....
July 2010 Br J Cardiol 2010;17:168-170
Report from the 20th Scientific Meeting of the European Society of Hypertension, Oslo, Norway
Renal denervation (RDN) revisited A novel, catheter-based technique is looking promising for the treatment of refractory hypertension. Renal sympathetic hyperactivity is associated with the development...July 2010 Br J Cardiol 2010;17:163-5
New NICE guidance on prevention of cardiovascular disease at the population level
The National Institute for Health and Clinical Excellence (NICE) has published a new guidance on prevention of cardiovascular disease at the population level....July 2010 Br J Cardiol 2010;17:163-5
Testosterone trial stopped due to cardiovascular events
A trial testing testosterone gel in older men with mobility limitations has been stopped early because of an increased risk of cardiovascular events in...July 2010 Br J Cardiol 2010;17:163-5
Apixaban beneficial in atrial fibrillation
A study of a new drug for atrial fibrillation, apixaban (Pfizer/Bristol-Myers Squibb), has been stopped early because of...July 2010 Br J Cardiol 2010;17:163-5
Eplerenone beneficial in mild heart failure
Another trial stopped early because of benefit is EMPHASIS-HF (Eplerenone in Mild Patients Hospitalisation And SurvIval Study in Heart Failure) which looked at the...July 2010 Br J Cardiol 2010;17:163-5
Treat individual risk factors not ‘metabolic syndrome’
A new study suggests that patients with metabolic syndrome are no more at risk of future myocardial infarction (MI) than those with diabetes or...July 2010 Br J Cardiol 2010;17:163-5
The British Valve Group – a new special interest group
The influence and importance of valve disease is increasing and yet the subject remains under-represented. There is, for example, no group affiliated to the...July 2010 Br J Cardiol 2010;17:163-5
Lp(a) screening recommended by European Atherosclerosis Society
Patients at moderate to high risk of cardiovascular disease should be screened for elevated Lp(a) and take niacin to lower levels to under 50...July 2010 Br J Cardiol 2010;17:163-5
England sees MI reduction after smoking ban
A new study has confirmed that there has been a significant drop in hospital admissions for myocardial infarction (MI) after the introduction of smoke-free...July 2010 Br J Cardiol 2010;17:163-5
Is the EWTD failing the welfare of junior doctors?
To find out how the European Working Time Directive set up to help improve the welfare of junior doctors seems to be failing in...July 2010 Br J Cardiol 2010;17:171-2
A glossary of terms used in interventional cardiology: part 2
We continue our series in which Consultant Interventionist Dr Michael Norell takes a sideways look at life in the cath lab…and beyond. In this...July 2010
Book review – Evidence-based cardiology, 3rd edition
By the very nature of book publishing, a relevant evidence-based textbook is always a hard task to achieve. The editors of Evidence-based cardiology preface...May 2010 Br J Cardiol 2010;17:109-10
New NICE guidance on acute coronary syndromes
A new guideline has been published by the National Institute for Health and Clinical Excellence (NICE) and the National Clinical Guidelines Centre for Acute...May 2010 Br J Cardiol 2010;17:109-10
New NICE guidance on chest pain of recent onset
It is hoped that a new National Institute for Health and Clinical Excellence (NICE) guideline on recent onset chest pain will lead to a...May 2010 Br J Cardiol 2010;17:109-10
Other NICE updates
Dronedarone included in new appraisal consultation document An independent Appraisal Committee has revised NICE’s original recommendation that dronedarone should not be used to treat atrial...
May 2010 Br J Cardiol 2010;17:111-5
News from the 59th Annual Scientific Session of the American College of Cardiology
Neither intensive blood pressure reduction, or adding a fibrate to a statin, appear to be justified in patients with diabetes at high risk of...
May 2010 Br J Cardiol 2010;17:118-9
Top secret; for your eyes only
We continue our series in which Consultant Interventionist Dr Michael Norell takes a sideways look at life in the cath lab…and beyond. In this...May 2010 Br J Cardiol 2010;17:152
Book Review – Cardioprotection
For more than 30 years, the term ‘cardioprotection’ has been applied widely and often without precision to sundry interventions that reduce the incidence and...May 2010 Br J Cardiol 2010;17:152
Book review – Cardiovascular risk management
My initial reaction on reading this slim, elegant volume was a twinge of professional jealousy which was rapidly replaced by enjoyment. An important feature...March 2010 Br J Cardiol 2010;17:59-61
New NICE guidance on VTE prevention
The National Institute for Health and Clinical Excellence (NICE) has issued new guidance on the prevention of venous thromboembolism (VTE) in patients admitted to...
March 2010 Br J Cardiol 2010;17:59-61
NICE preliminary hearing negative on new antiarrhythmic
The National Institute for Health and Clinical Excellence (NICE) has issued a draft guidance on the new anti-arrhythmic drug, dronedarone, saying it does not...
March 2010 Br J Cardiol 2010;17:59-61
What is the best blood sugar level in diabetics? –New UK data
A new UK study has suggested that both very low and very high blood sugar levels in type 2 diabetes are associated with increased...March 2010 Br J Cardiol 2010;17:59-61
Hormone replacement therapy and heart disease risk in younger women
Among recently menopausal women, hormone replacement therapy (HRT) with both oestrogen and progestin, showed a slight non-significant increase in risk of coronary heart disease...
March 2010 Br J Cardiol 2010;17:59-61
Cardiovascular services in London – the case for change
A document outlining how London’s acute and complex cardiovascular services are currently provided and broad principles for how things could be improved, Cardiovascular services...March 2010 Br J Cardiol 2010;17:59-61
Statins appear to increase risk of diabetes
A new meta-analysis has suggested that use of statins slightly increases the risk of developing diabetes. The analysis – published in the February 27th...
March 2010 Br J Cardiol 2010;17:64-6
“Doctor knows best”… Perhaps; but which one?
We continue our series in which Consultant Interventionist Dr Michael Norell takes a sideways look at life in the cath lab…and beyond. In this...March 2010 Br J Cardiol 2010;17:67-8
Cardiorenal syndrome: one disease – two paths?
A report from the fourth Annual Scientific Meeting of the Cardiorenal...March 2010 Br J Cardiol 2010;17:69-70
The British Society for Heart Failure 12th Annual Autumn Meeting
Highlights of this year’s British Society for Heart Failure (BSH) meeting, held in November in London, included a call for specialist heart failure units...November 2009 Br J Cardiol 2009;16:269-71
Pericardial fat – a good predictor of future heart disease
Fat around the heart— known as pericardial fat— may be a better predictor of future heart disease than either body mass index (BMI) or...November 2009 Br J Cardiol 2009;16:269-71
CHD risk is being overestimated in diabetes
The Framingham and UKPDS (United Kingdom Prospective Diabetes Study) risk equations overestimate the probability of cardiovascular events in people with type 2 diabetes, according...November 2009 Br J Cardiol 2009;16:269-71
New Bluetooth stethoscope available
A new stethoscope – the Littmann 3200 – is now available which is the first to enable Bluetooth transfer of sounds to software for...November 2009 Br J Cardiol 2009;16:269-71
Hypothermia improves outcomes after cardiac arrest
Conventional cooling methods can improve survival and reduce neurologic injury after cardiac arrest, a new Cochrane Review...November 2009 Br J Cardiol 2009;16:269-71
BLOSSOM: new weight loss drug on the horizon
A new drug, lorcaserin, showed good weight loss results without the valvular side-effects associated with some other serotonin type agents in the Phase III...November 2009 Br J Cardiol 2009;16:269-71
NT-proBNP predicts atrial fibrillation
N-terminal pro-B-type natriuretic peptide (NT-proBNP) is a “remarkable predictor” of incident atrial fibrillation (AF), even after adjustment for other known risk factors, according to...November 2009 Br J Cardiol 2009;16:269-71
Increasing treatment window for tPA in stroke
New analyses of data from ECASS 3 (Third European Cooperative Acute Stroke Study) suggest that the thrombolytic, tPA (alteplase) has benefits in the treatment...November 2009 Br J Cardiol 2009;16:269-71
Clopidogrel needed for more than one year after drug-eluting stent placement?
Extending clopidogrel treatment from one to two years after drug-eluting stent placement is associated with a reduction in very late thromboses, new registry data...November 2009 Br J Cardiol 2009;16:269-71
Niacin shows plaque regression
The use of niacin was associated with a regression of atherosclerotic plaque in a new imaging...November 2009 Br J Cardiol 2009;16:272
In brief
...November 2009 Br J Cardiol 2009;16:273
News from TCT 2009
The Transcatheter Cardiovascular Therapeutics 2009 meeting was held in San Francisco, USA, from September 22nd –...November 2009 Br J Cardiol 2009;16:276-7
Making change happen: the PCCS Annual Scientific Meeting
‘Making change happen’ was the theme of the 12th Annual Scientific Meeting of the Primary Care Cardiovascular Society (PCCS) in Nottingham on 1st –...November 2009 Br J Cardiol 2009;16:278-9
Hey ho for the open road
We continue our series in which Consultant Interventionist Dr Michael Norell takes a sideways look at life in the cath lab…and beyond. In this...September 2009 Br J Cardiol 2009;16:215-221
News from the 2009 Congress of the European Society of Cardiology
This year’s European Society of Cardiology (ESC) congress, held in Barcelona, Spain, from August 29th–September 2nd 2009, was awash with promising new data, including...September 2009 Br J Cardiol 2009;16:223-225
Lipid hypothesis proves its case at HEART UK conference
HEART UK – The Cholesterol Charity held its 23rd annual conference in Liverpool in June, focussing on understanding clinical trials and the evidence base...September 2009 Br J Cardiol 2009;16:227-228
I never take advice, as a rule
We continue our series in which Consultant Interventionist Dr Michael Norell takes a sideways look at life in the cath lab…and beyond. In this...July 2009 Br J Cardiol 2009;16:163-6
New NICE guidelines on new treatments for type 2 diabetes
The National Institute for Health and Clinical Excellence (NICE) has issued a new guidance on the use of several newer agents for blood glucose...July 2009 Br J Cardiol 2009;16:163-6
New meta-analysis confirms statin benefit in primary prevention
A new meta-analysis has confirmed that statins improve survival and reduce the risk of major cardiovascular events in patients who have risk factors but...July 2009 Br J Cardiol 2009;16:163-6
EMEA warns of possible interaction between clopidogrel and PPIs
The European Medicines Agency (EMEA) has issued a warning about a possible interaction between clopidogrel and proton-pump inhibitors (PPIs), such as omeprazole, which are...July 2009 Br J Cardiol 2009;16:163-6
Generic clopidogrel imminent
The European Medicines Agency (EMEA) has given a positive recommendation to six generic versions of clopidogrel. Such recommendations are normally endorsed by the European...July 2009 Br J Cardiol 2009;16:163-6
New programme acts as virtual coach and motivator in patient heart health
A new diet and lifestyle support programme has been launched online for patients once they have completed an NHS Health Check. It is hoped...July 2009 Br J Cardiol 2009;16:163-6
Everyone over a certain age should take an antihypertensive?
Further support for the idea of giving antihypertensive drugs to everyone over a certain age, regardless of their blood pressure, has come from the...July 2009 Br J Cardiol 2009;16:163-6
Liraglutide: novel drug for type 2 diabetes launched
The first once-daily human glucagon-like peptide 1 (GLP-1) analogue, liraglutide (Victoza) for the treatment of type 2 diabetes mellitus (T2DM) has been launched in...July 2009 Br J Cardiol 2009;16:169–70
British Cardiovascular Society Annual Scientific Conference 2009
A busy three-day programme comprised this year’s meeting at the ExCel Centre, London, from 1st–3rd June 2009. We report on a few of the...July 2009 Br J Cardiol 2009;16:173-4
Sorry you’re leaving …
We continue our series in which Consultant Interventionist Dr Michael Norell takes a sideways look at life in the cath lab…and beyond. In this...July 2009 Br J Cardiol 2009;16:200
Sudden cardiac death
This book largely reflects writers from Italian and German practise on sudden death. It begins with a definition and introduction to sudden death and...May 2009 Br J Cardiol 2009;16:121-125
News from the 58th Annual Scientific Session of the American College of Cardiology
The 2009 American College of Cardiology (ACC) meeting was held in Orlando, US, from March 29th–31st 2009. Highlights this year included the first major...March 2009 Br J Cardiol 2009;16:63-64
Prasugrel approved in Europe
The new antiplatelet agent, prasugrel (Lilly/Daiichi Sankyo), has been approved in the European Union for the prevention of atherothrombotic events in patients with acute...March 2009 Br J Cardiol 2009;16:63-64
Don’t take proton pump inhibitors with clopidogre
New evidence has been reported suggesting that use of proton pump inhibitors (PPIs) such as omeprazole can reduce the effectiveness of clopidogrel. In a recent...March 2009 Br J Cardiol 2009;16:69-71
Is this a conference you want to attend?
We continue our series in which Consultant Interventionist Dr Michael Norell takes a sideways look at life in the cath lab…and beyond. In this...January 2009 Br J Cardiol 2009;16:9–10
Rapid access blackout clinics: a priority for the elderly
“Old age starts with the first fall and death comes with the second.”1 Syncopal events and falls are a major healthcare and cost burden for...January 2009 Br J Cardiol 2009;16:11–12
Periodontal disease – another cardiovascular risk factor to consider?
General practitioners (GPs) have become used to asking their patients fairly detailed questions about the traditional risk factors, such as smoking habits, and measuring...January 2009 Br J Cardiol 2009;16:13-14
The mouse is mightier than the pen
We continue our series in which Consultant Interventionist Dr Michael Norell takes a sideways look at life in the cath lab… and beyond. In...January 2009 Br J Cardiol 2009;16:16-14
New heart failure report
A new report Focus on heart failure, by the NHS Institute for Innovation and Improvement, aims to provide primary and secondary care services with guidance...January 2009 Br J Cardiol 2009;16:17-19
Combating vascular disease in Scotland: 20 years of SHARP
The Scottish Heart and Arterial Risk Prevention Group (SHARP) was launched in 1988 with the aim of helping to reduce and prevent premature morbidity...January 2009 Br J Cardiol 2009;16:20-21
Cardiovascular disease and deprivation
A busy and varied programme discussing some of the hottest topics in cardiovascular disease was presented at the 11th Primary Care Cardiovascular Society (PCCS)...January 2009 Br J Cardiol 2009;16:42
Cardiovascular magnetic resonance made easy
Cardiovascular magnetic resonance (CMR) is a safe and accurate imaging modality, with an established role in current cardiology practice. It is becoming essential for...November 2008 Br J Cardiol 2008;15:284–8
News from the Scientific Sessions 2008 of the American Heart Association
Major new trials reported at the American Heart Association 2008 Scientific Sessions, held in New Orleans on November 8th – 12th, showed encouraging results...November 2008 Br J Cardiol 2008;15:293
Patient-activated ECG system shows high diagnostic accuracy for AF and other arrhythmias
News in brief from the world of...November 2008 Br J Cardiol 2008;15:293
New national guideline on emergency oxygen use in adults
News in brief from the world of...November 2008 Br J Cardiol 2008;15:293
New study on HRT and risk of MI
News in brief from the world of...November 2008 Br J Cardiol 2008;15:293
Kellogg’s team up with H·E·A·R·T UK
News in brief from the world of...November 2008 Br J Cardiol 2008;15:301
News from the EASD
This year’s European Association for the Study of Diabetes meeting took place in Rome, Italy. Rhonda Siddall reports on the highlights of the meeting,...September 2008 Br J Cardiol 2008;15:231-36
News from the 2008 Congress of the European Society of Cardiology
Highlights of the European Society of Cardiology meeting held in Munich, Germany, August 30th – September 3rd 2008 showed further benefit for fish oils,...July 2008 Br J Cardiol 2008;15:185-88
News
General news from the world of...July 2008 Br J Cardiol 2008;15:189
Controversies in cardiovascular care
The Primary Care Cardiovascular Society (PCCS) teamed up with the South East Wales Cardiac Network for the first joint regional meeting of the Society....May 2008 Br J Cardiol 2008;15:123–30
News from the 57th annual scientific session of the American College of Cardiology
The 2008 American College of Cardiology meeting was held jointly with the Society for Cardiac Angiography and Interventions Annual Meeting on March 29th –...May 2008 Br J Cardiol 2008;15:134–6
2007 BJCA survey of cardiology trainees
The fourth annual survey from the British Junior Cardiologists Association (BJCA) reports at a time of restructuring of higher specialist training in the UK....March 2008 Br J Cardiol 2008;15:68-9
NICE issues new draft guidance on drug-eluting stents
The National Institute for Health and Clinical Excellence (NICE) has recommended that drug-eluting stents can continue to be used in patients who have a...March 2008 Br J Cardiol 2008;15:68-9
Questions raised on very intensive glucose lowering in type 2 diabetes
The results of two major trials of intensive glucose lowering in patients with type 2 diabetes appear to have reached different...March 2008 Br J Cardiol 2008;15:68-9
ADVANCE shows no harm
In contrast, the ADVANCE study, has not shown any harm in its intensive treatment arm. In this trial, 11,140 high-risk patients with type 2...March 2008 Br J Cardiol 2008;15:68-9
Cardiovascular mortality patterns in Europe
A new study has highlighted a changing pattern of cardiovascular mortality within Europe, and shows that while cardiovascular mortality rates are decreasing in general,...January 2008 Br J Cardiol 2008;15:6
Primary care heart failure services
There is a need to meet the demand, led by primary care, for the appropriate assessment and management of patients with heart failure. Standard...January 2008 Br J Cardiol 2008;15:7–11
New cardiovascular screening programmes planned
As part of a larger focus on prevention of disease in the NHS, Prime Minister Gordon Brown has announced that new screening programmes for...January 2008 Br J Cardiol 2008;15:7-11
Early trials suggest benefit with second CETP inhibitor
The first clinical trials with the new cholesteryl ester transfer protein (CETP) inhibitor, anacetrapib, have raised hopes that this agent may not be affected...January 2008 Br J Cardiol 2008;15:7-11
Vitamin D deficiency ups risk of heart disease?
As well as causing musculoskeletal problems, vitamin D deficiency may also increase the risk of heart disease, a new study...January 2008 Br J Cardiol 2008;15:7-11
New computer simulation of the heart to aid cardiologist/surgeon training
Anatomy software developer, Primal Pictures, has been awarded government grants to develop two new computer simulations which should improve training procedures for cardiologists and...January 2008 Br J Cardiol 2008;15:7-11
Another study shows increased CV risk with rosiglitazone
Another study has suggested increased risk of cardiovascular (CV) events with the diabetes drug, rosiglitazone. In the retrospective case-control study (JAMA 2007;298:2634–43), rosiglitazone was...January 2008 Br J Cardiol 2008;15:7-11
UK approves testing embryos for FH
The UK Human Fertilisation and Embryology Authority (HFEA) has granted permission for pre-implantation genetic diagnosis of familial hypercholesterolaemia (FH) to be performed for the...January 2008 Br J Cardiol 2008;15:7-11
Better to be fat than unfit?
Being unfit is an independent predictor of all-cause mortality, even after adjustment for body fat, according to a new study (JAMA 2007;...January 2008 Br J Cardiol 2008;15:7-11
New cholesterol-lowering product
Genzyme has launched its new non-absorbed cholesterol-lowering agent, colesevelam hydrochloride (CholestagelTM) in Europe for the treatment of adult patients with primary hypercholesterolaemia who cannot...January 2008 Br J Cardiol 2008;15:7-11
Moderate alcohol consumption improves risk
A study, published in the European Heart Journal (7th January issue), has shown that people who drink moderate amounts of alcohol and are physically...January 2008 Br J Cardiol 2008;15:7-11
New pacemaker may help more syncope patients
Cardiologists from St Mary’s Hospital, London, have become the first in the world to implant a new generation of pacemaker that could help more...January 2008 Br J Cardiol 2008;15:7-11
New ‘healing’ stent looks promising
A new stent which may promote healing of the artery better than currently available drug-eluting stents has shown promising results in initial clinical trials....January 2008 Br J Cardiol 2008;15:7-11
ENHANCE study shows no benefit of ezetimibe
The first study to investigate the efficacy of the cholesterol absorption inhibitor, ezetimibe, has shown no benefit of the drug in an imaging study...January 2008 Br J Cardiol 2008;15:7-11
State-of-the-art virtual simulators
State-of-the-art virtual simulators (see right) and a virtual in-house catheterisation laboratory to help physicians learn about the latest cardiac and vascular treatment techniques are...January 2008 Br J Cardiol 2008;15:19
Please give generously …
We continue our series in which Consultant Interventionist Dr Michael Norell takes a sideways look at life in the cath lab…and beyond. In this...
September 2007 Br J Cardiol 2007;14:205–18
Things you always wanted to know about … the stethoscope
We continue our series in which Consultant Interventionist Dr Michael Norell takes a sideways look at life in the cath lab…and beyond. In this...November 2006 Br J Cardiol 2006;13:383-4
News
Italian public smoking ban leads to fall in MI rates New cardio-renal group launched Community-based intervention shows promise New editorial board...July 2006 Br J Cardiol 2006;13:239-44
News
NICE updates its hypertension guidance A general practitioner’s view of the new guidance Rimonabant launched for obesity treatment New home monitoring technology gives greater control to chronic...May 2006 Br J Cardiol 2006;13:169
News
NICE issues guidance on smoking cessation and physical activity World Heart Day to focus on diet and exercise for a ‘young’...November 2005 Br J Cardiol 2005;12:441
Progress in cardiology in northern England?
Patients attending cardiology clinics, particularly those with chronic heart failure (CHF), frequently have co-morbidities and attend other hospital medical clinics. We examined the case...July 2005 Br J Cardiol 2005;12:268-9
New analysis of LIFE trial shows reduction of new-onset atrial fibrillation with losartan
A new analysis of the LIFE study has shown that losartan can reduce new-onset atrial fibrillation in hypertensive patients with left ventricular hypertrophy. General...May 2005 Br J Cardiol 2005;12:192-8
National variations in the provision of cardiac services in the United Kingdom
We publish in full this report by a working group of the British Cardiac Society which shows large disparities in cardiac services between England,...March 2005 Br J Cardiol 2005;12:142-4
Current ECG telemetry practice in the UK: a national audit
Electrocardiographic monitoring by telemetry has become commonplace throughout the UK. This survey was designed to assess its availability, to determine current practice and so...March 2005 Br J Cardiol 2005;12:139-41
A brief report on the data available on rapid access cardiology clinics
Rapid Access Cardiology Clinics were introduced many years ago for the assessment of chest pain. Following the publication of the National Service Framework (NSF)...September 2004 Br J Cardiol 2004;11:399-02
Community echocardiography for heart failure
A consensus statement from representatives of the British Society of Echocardiography, the British Heart Failure Society, the Coronary Heart Disease Collaborative and the Primary Care Cardiovascular...September 2004 Br J Cardiol 2004;11:369-75
The prevalence and natural history of anaemia in an optimally treated heart failure population
The prevalence of anaemia in heart failure (HF) is becoming better recognised, yet little is known about its natural history in a HF population. We...March 2004 Br J Cardiol 2004;11:106-11
Improving secondary prevention of coronary heart disease: using the new GP contract to drive change
This is the final article in a series examining how the Coronary Heart Disease Collaborative (CHDC) supports clinical teams to improve services for coronary...January 2004 Br J Cardiol 2004;11:24-6
Cardiac surgery – improvement along the patient pathway
We continue our series on the work of the Coronary Heart Disease Collaborative (CHDC), which is part of the NHS Modernisation Agency. In this...November 2003 Br J Cardiol 2003;10:450-2
Non-surgical aortic valve replacement
Percutaneous aortic valve replacement, a new technique developed to overcome the problem of restenosis of the native valve in patients treated with balloon aortic...November 2003 Br J Cardiol 2003;10:446-9
The angina journey: a major challenge in cardiology
Patients with suspected angina pectoris pose a major challenge to all levels of cardiology services. Their pathway through their NHS care can involve many...July 2003 Br J Cardiol 2003;10:269-71
Better care without delay: cardiac rehabilitation
Cardiac rehabilitation received full support in the National Service Framework (NSF) for Coronary Heart Disease...May 2003 Br J Cardiol 2003;10:189-92
Better care without delay: heart failure
Better care without delay: heart failure Coronary Heart Disease Collaborative Heart failure is a subject that is equally challenging to primary and secondary care...March 2003 Br J Cardiol 2003;10:101-4
Better care without delay: acute myocardial infarction
Exploring how the CHD Collaborative is helping clinical teams across the country achieve clear improvements in services for patients with coronary heart disease. Each...November 2002 Br J Cardiol 2002;9:590-2
Revascularisation and the diabetic patient: the potential role of drug-eluting stents
Revascularisation and the diabetic patient: the potential role of drug-eluting stents David Barrow David Barrow, a medical journalist with a special interest in interventional...September 2002 Br J Cardiol 2002;9:491-2
